References

Abhyankar, L.N., M.R. Jones, E. Guallar, and A. Navas-Acien. 2012. Arsenic exposure and hypertension: A systematic review. Environ. Health Perspect. 120(4):494-500.

Achanzar, W.E., E.M. Brambila, B.A. Diwan, M.M. Webber, and M.P. Waalkes. 2002. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94(24):1888-1891.

Acharya, S., S. Chaudhuri, S. Chatterjee, P. Kumar, Z. Begum, S. Dasgupta, S.J. Flora, and S. Chaudhuri. 2010. Immunological profile of arsenic toxicity: A hint towards arsenic-induced carcinogenesis. Asian Pac. J. Cancer Prev. 11(2):479-490.

Adami, H.O., C.L. Berry, C.B. Breckenridge, L.L. Smith, J.A. Swenberg, D. Trichopoulos, N.S. Weiss, and T.P. Pastoor. 2011. Toxicology and epidemiology: Improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol. Sci. 122(2):223-234.

Agusa, T., J. Fujihara, H. Takeshita, and H. Iwata. 2011. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 12(4):2351-2382.

Agusa, T., T. Kunito, N.M. Tue, V.T. Lan, J. Fujihara, H. Takeshita, T.B. Minh, P.T. Trang, S. Takahashi, P.H. Viet, S. Tanabe, and H. Iwata. 2012. Individual variations in arsenic metabolism in Vietnamese: The association with arsenic exposure and GSTP1 genetic polymorphism. Metallomics 4(1):91-100.

Ahmad, S.A., M.H. Sayed, S. Barua, M.H. Khan, M.H. Faruqee, A. Jalil, S.A. Hadi, and H.K. Talukder. 2001. Arsenic in drinking water and pregnancy outcomes. Environ. Health Perspect. 109(6):629-631.

Ahmed, S., S. Mahabbat-e Khoda, R.S. Rekha, R.M. Gardner, S.S. Ameer, S. Moore, E.C. Ekström, M. Vahter, and R. Raqib. 2011. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ. Health Perspect. 119(2):258-264.

Ahmed, S., K.B. Ahsan, M. Kippler, A. Mily, Y. Wagatsuma, A.M. Hoque, P.G. Ngom, S. El Arifeen, R. Raqib, and M. Vahter. 2012. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol. Sci. 129(2):305-314.

Ahsan, H., Y. Chen, F. Parvez, L. Zablotska, M. Argos, I. Hussain, H. Momotaj, D. Levy, Z. Cheng, V. Slavkovich, A. van Geen, G.R. Howe, and J.H. Graziano. 2006. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: Baseline results from the health effects of arsenic longitudinal study. Am. J. Epidemiol. 163(12):1138-1148.

Ahsan, H., Y. Chen, M.G. Kibriya, V. Slavkovich, F. Parvez, F. Jasmine, M.V. Gamble, and J.H. Graziano. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16(6):1270-1278.

Allison, D.B., X. Cui, G.P. Page, and M. Sabripour. 2006. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 7(1):55-65.

Altar, C.A., D. Amakye, D. Bounos, J. Bloom, G. Clack, R. Dean, V. Devanarayan, D. Fu, S. Furlong, L. Hinman, C. Girman, C. Lathia, L. Lesko, S. Madani, J. Mayne, J. Meyer, D. Raunig, P. Sager, S.A. Williams, P. Wong, and K. Zerba. 2008. A prototypical process for creating evidentiary standards for biomarkers and diagnostics. Clin. Pharmacol. Ther. 83(2):368-371.

Amaral, A.F., M. Porta, D.T. Silverman, R.L. Milne, M. Kogevinas, N. Rothman, K.P. Cantor, B.P. Jackson, J.A. Pumarega, T. López, A. Carrato, L. Guarner, F.X. Real, and N. Malats. 2012. Pancreatic cancer risk and levels of trace elements. Gut 61(11):1583-1588.

Andersen, M.E., M.E. Meek, G.A. Boorman, D.J. Brusick, S.M. Cohen, Y.P. Dragan, C.B. Frederick, J.I. Goodman, G.C. Hard, E.J. O'Flaherty, and D.E. Robinson. 2000. Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. Toxicol. Sci. 53(2):159-172.

Andrew, A.S., R.A. Mason, V. Memoli, and E.J. Duell. 2009a. Arsenic activates EGFR pathway signaling in the lung. Toxicol. Sci. 109(2):350-357.

Andrew, A.S., R.A. Mason, K.T. Kelsey, A.R. Schned, C.J. Marsit, H.H. Nelson, and M.R. Karagas. 2009b. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol. Lett. 187(1):10-14.

Andujar, P., J. Wang, A. Descatha, F. Galateau-Salle, I. Abd-Alsamad, M.A. Billon-Galland, H. Blons, B. Clin, C. Danel, B. Housset, P. Laurent-Puig, F. Le Pimpec-Barthes, M. Letourneux, I. Monnet, J.F. Regnard, A.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 84
References Abhyankar, L.N., M.R. Jones, E. Guallar, and A. Navas-Acien. 2012. Arsenic exposure and hypertension: A sys- tematic review. Environ. Health Perspect. 120(4):494-500. Achanzar, W.E., E.M. Brambila, B.A. Diwan, M.M. Webber, and M.P. Waalkes. 2002. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94(24):1888-1891. Acharya, S., S. Chaudhuri, S. Chatterjee, P. Kumar, Z. Begum, S. Dasgupta, S.J. Flora, and S. Chaudhuri. 2010. Immunological profile of arsenic toxicity: A hint towards arsenic-induced carcinogenesis. Asian Pac. J. Cancer Prev. 11(2):479-490. Adami, H.O., C.L. Berry, C.B. Breckenridge, L.L. Smith, J.A. Swenberg, D. Trichopoulos, N.S. Weiss, and T.P. Pastoor. 2011. Toxicology and epidemiology: Improving the science with a framework for combining toxi- cological and epidemiological evidence to establish causal inference. Toxicol. Sci. 122(2):223-234. Agusa, T., J. Fujihara, H. Takeshita, and H. Iwata. 2011. Individual variations in inorganic arsenic metabolism asso- ciated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 12(4):2351-2382. Agusa, T., T. Kunito, N.M. Tue, V.T. Lan, J. Fujihara, H. Takeshita, T.B. Minh, P.T. Trang, S. Takahashi, P.H. Viet, S. Tanabe, and H. Iwata. 2012. Individual variations in arsenic metabolism in Vietnamese: The asso- ciation with arsenic exposure and GSTP1 genetic polymorphism. Metallomics 4(1):91-100. Ahmad, S.A., M.H. Sayed, S. Barua, M.H. Khan, M.H. Faruqee, A. Jalil, S.A. Hadi, and H.K. Talukder. 2001. Ar- senic in drinking water and pregnancy outcomes. Environ. Health Perspect. 109(6):629-631. Ahmed, S., S. Mahabbat-e Khoda, R.S. Rekha, R.M. Gardner, S.S. Ameer, S. Moore, E.C. Ekström, M. Vahter, and R. Raqib. 2011. Arsenic-associated oxidative stress, inflammation, and immune disruption in human pla- centa and cord blood. Environ. Health Perspect. 119(2):258-264. Ahmed, S., K.B. Ahsan, M. Kippler, A. Mily, Y. Wagatsuma, A.M. Hoque, P.G. Ngom, S. El Arifeen, R. Raqib, and M. Vahter. 2012. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol. Sci. 129(2):305-314. Ahsan, H., Y. Chen, F. Parvez, L. Zablotska, M. Argos, I. Hussain, H. Momotaj, D. Levy, Z. Cheng, V. Slavkovich, A. van Geen, G.R. Howe, and J.H. Graziano. 2006. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: Baseline results from the health effects of arsenic longitudinal study. Am. J. Epidemiol. 163(12):1138-1148. Ahsan, H., Y. Chen, M.G. Kibriya, V. Slavkovich, F. Parvez, F. Jasmine, M.V. Gamble, and J.H. Graziano. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16(6):1270-1278. Allison, D.B., X. Cui, G.P. Page, and M. Sabripour. 2006. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 7(1):55-65. Altar, C.A., D. Amakye, D. Bounos, J. Bloom, G. Clack, R. Dean, V. Devanarayan, D. Fu, S. Furlong, L. Hinman, C. Girman, C. Lathia, L. Lesko, S. Madani, J. Mayne, J. Meyer, D. Raunig, P. Sager, S.A. Williams, P. Wong, and K. Zerba. 2008. A prototypical process for creating evidentiary standards for biomarkers and diagnostics. Clin. Pharmacol. Ther. 83(2):368-371. Amaral, A.F., M. Porta, D.T. Silverman, R.L. Milne, M. Kogevinas, N. Rothman, K.P. Cantor, B.P. Jackson, J.A. Pumarega, T. López, A. Carrato, L. Guarner, F.X. Real, and N. Malats. 2012. Pancreatic cancer risk and levels of trace elements. Gut 61(11):1583-1588. Andersen, M.E., M.E. Meek, G.A. Boorman, D.J. Brusick, S.M. Cohen, Y.P. Dragan, C.B. Frederick, J.I. Goodman, G.C. Hard, E.J. O'Flaherty, and D.E. Robinson. 2000. Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. Toxicol. Sci. 53(2):159-172. Andrew, A.S., R.A. Mason, V. Memoli, and E.J. Duell. 2009a. Arsenic activates EGFR pathway signaling in the lung. Toxicol. Sci. 109(2):350-357. Andrew, A.S., R.A. Mason, K.T. Kelsey, A.R. Schned, C.J. Marsit, H.H. Nelson, and M.R. Karagas. 2009b. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol. Lett. 187(1):10-14. Andujar, P., J. Wang, A. Descatha, F. Galateau-Salle, I. Abd-Alsamad, M.A. Billon-Galland, H. Blons, B. Clin, C. Danel, B. Housset, P. Laurent- Puig, F. Le Pimpec-Barthes, M. Letourneux, I. Monnet, J.F. Regnard, A. 84

OCR for page 84
References 85 Renier, J. Zucman-Rossi, J.C. Pairon, and M.C. Jaurand. 2010. p16INK4A Inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer 67(1):23-30. Ankley, G.T., R.S. Bennett, R.J. Erickson, D.J. Hoff, M.W. Hornung, R.D. Johnson, D.R. Mount, J.W. Nichols, C.L. Russom, P.K. Schmieder, J.A. Serrano, J.E. Tietge, and D.L. Villeneuve. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxi- col. Chem. 29(3):730-741. Applebaum, K.M., M.R. Karagas, D.J. Hunter, P.J. Catalano, S.H. Byler, S. Morris, and H.H. Nelson. 2007. Poly- morphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ. Health Perspect. 115(8):1231-1236. Arnold, L.L., S. Suzuki, M. Yokohira, S. Makiuchi-Kiyota, K.L. Pennington, and S.M. Cohen. 2013. Time course of urothelial changes in rats and mice orally administered arsenite. Toxicol. Pathol. doi: 10.1177/019262331 3489778. Argos, M., T. Kalra, B.L. Pierce, Y. Chen, F. Parvez, T. Islam, A. Ahmed, R. Hasan, K. Hasan, G. Sarwar, D. Levy, V. Slavkovich, J.H. Graziano, P.J. Rathouz, and H. Ahsan. 2011. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am. J. Epidemiol. 174(2):185-194. ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Arsenic. U.S. De- partment of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp2.pdf [accessed Mar. 4, 2013]. ATSDR (Agency for Toxic Substances and Disease Registry). 2009. 2003 CERCLA Priority List of Hazardous Substances [online]. Available: http://www.atsdr.cdc.gov/spl/previous/03list.html [accessed July 5, 2013]. Aung, K.H., R. Kurihara, S. Nakashima, F. Maekawa, K. Nohara, T. Kobayashi, and S. Tsukahara. 2013. Inhibition of neurite outgrowth and alteration of cytoskeletal gene expression by sodium arsenite. Neurotoxicology 34:226-235. Ayotte, J.D., D. Baris, K.P. Cantor, J. Colt, G.R. Robinson, J.H. Lubin, M.R. Karagas, R.N. Hoover, J.F. Fraumeni, and D.T. Silverman. 2006. Bladder cancer mortality and private well use in New England: An ecological study. J. Epidemiol. Community Health 60(2):168-172. Ayotte, J.D., J.M. Gronberg, and L.E. Apodaca. 2011. Trace Elements and Radon in Groundwater Across the United States, 1992-2003. Scientific Investigations Report 2011-5059. U.S. Geological Survey [online]. Available: http://pubs.usgs.gov/sir/2011/5059/pdf/sir2011-5059_report-covers_508.pdf [accessed July 20, 2013]. Baastrup, R., M. Sorensen, T. Balstrom, K. Frederiksen, C.L. Larsen, A. Tjonneland, K. Overvad, and O. Raaschou- Nielsen. 2008. Arsenic in drinking-water and risk for cancer in Denmark. Environ. Health Perspect. 116(2): 231-237. Bao, L., and H. Shi. 2010. Potential molecular mechanisms for combined toxicity of arsenic and alcohol. J. Inorg. Biochem. 104(12):1229-1233. Bardullas, U., J.H. Limon-Pacheco, M. Giordano, L. Carrizales, M.S. Mendoza-Trejo, and V.M. Rodriguez. 2009. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol. Appl. Pharmacol. 239(2):169-177. Barr, D.B., L.C. Wilder, S.P. Caudill, A.J. Gonzalez, L.L. Needham, and J.K. Prikle. 2005. Urinary creatinine concen- tration in the US population: implications for urinary biologic monitoring measurements. Environ. Health Per- spect. 113(2):192-200. Basu, A., S. Mitra, J. Chung, D.N. Guha Mazumder, N. Ghosh, D. Kalman, O. von Ehrenstein, C. Steinmaus, J. Liaw, and A.H. Smith. 2011. Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Envi- ron. Health Perspect. 119(9):1308-1313. Bates, M.N., A.H. Smith, and K.P. Cantor. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141(6):523-530. Bates, M.N., O.A. Rey, M.L. Biggs, C. Hopenhayn, L.E. Moore, D. Kalman, C. Steinmaus, and A.H. Smith. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 159(4):381-389. Beane Freeman, L.E., L.K. Dennis, C.F. Lynch, P.S. Thorne, and C.L. Just. 2004. Toenail arsenic content and cutaneous melanoma in Iowa. Am. J. Epidemiol. 160(7):679-687. Beck, B.D. 2013. Risk Assessment Approaches and Application of IRIS Values: Consideration of Susceptibility and Variability. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identifica- tion and Dose-Response Analysis, April 4, 2013, Washington, DC. Beebe-Dimmer, J.L., P.T. Iyer, J.O. Nriagu, G.R. Keele, S. Mehta, J.R. Melikar, E.M. Lange, A.G. Schwartz, K.A. Zuhlke, D. Schottenfeld, and K.A. Cooney. 2012. Genetic variation in glutathione S-transferase omega-1,

OCR for page 84
86 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: A case-control study. Environ. Health 11:43. doi: 10.1186/1476-069X-11-43. Beezhold, K., J. Liu, H. Kan, T. Meighan, V. Castranova, X. Shi, and F. Chen. 2011. miR-190- mediated downregula- tion of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol. Sci. 123(2):411- 420. Bellinger, D.C. 2007. Interpretation of small effect sizes in occupational and environmental neurotoxicology: Indi- vidual versus population risk. Neurotoxicology 28(2):245-251. Bellinger, D.C. 2013. Prenatal exposure to environmental chemicals and children’s neurodevelopment: An update. Saf. Health Work 4(1):1-11. Benbrahim-Tallaa, L., R.A. Waterland, M. Styblo, W.E. Achanzar, M.M. Webber, and M.P. Waalkes. 2005. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: Aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol. Appl. Pharmacol. 206(3):288-298. Benbrahim-Tallaa, L., M.M. Webber, and M.P. Waalkes. 2007. Mechanisms of acquired androgen independence dur- ing arsenic-induced malignant transformation of human prostate epithelial cells. Environ. Health Perspect. 115(2):243-247. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57(1):289-300. Bercu, J.P., R.A. Jolly, K.M. Flagella, T.K. Baker, P. Romero, and J.L. Stevens. 2010. Toxicogenomics and cancer risk assessment: A framework for key events analysis and dose-response assessment for nongenotoxic carcino- gens. Regul. Toxicol. Pharmacol. 58(3):369-381. Berlin, J.A., and G.A. Colditz. 1999. The role of meta-analysis in the regulatory process for foods, drugs, and devices. JAMA 281(9):830-834. Berlin, J.A., M.P. Longnecker, and S. Greenland. 1993. Meta-analysis of epidemiologic dose-response data. Epide- miology 4(3):218-228. Biscardi, J.S., M.C. Maa, D.A. Tice, M.E. Cox, T.H. Leu, and S.J. Parsons. 1999. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor func- tion. J. Biol. Chem. 274(12):8335-8343. Bodwell, J.E., L.A. Kingsley, and J.W. Hamilton. 2004. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not BR-mediated gene repression: Complex dose-response ef- fects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem. Res. Toxicol. 17(8):1064-1076. Bolstad, B.M., R.A. Irizarry, L. Gautier, and Z. Wu. 2005. Preprocessing high-density ligonucleotide arrays. Pp. 13- 32 in Bioinformatics and Computational Biology Solutions Using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber, eds. New York, NY: Springer. Boobis, A.R., S.M. Cohen, V. Dellarco, D. McGregor, M.E. Meek, C. Vickers, D. Willcocks, and W. Farland. 2006. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36(10):781-792. Boobis, A.R., J.E. Doe, B. Heinrich-Hirsh, M.E. Meek, S. Munn, M. Ruchirawat, J. Schlatter, J. Seed, and C. Vick- ers. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 38(2):87-96. Boobis, A.R., G.P. Daston, R.J. Preston, and S.S. Olin. 2009. Application of key vents analysis to chemical carcino- gens and noncarcinogens. Crit. Rev. Food Sci. Nutr. 49(8):690-707. Breton, C.V. W. Zhou, M.L. Kile, E.A. Houseman, Q. Quamruzzaman, M. Rahman, G. Mahiuddin, and D.C. Christia- ni. 2007. Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. Carcinogenesis 28(7):1520-1525. Broderick, P., L. Carvajal-Carmona, A.M. Pittman, E. Webb, K. Howarth, A. Rowan, S. Lubbe, S. Spain, K. Sullivan, S. Fielding, E. Jaeger, J. Vijayakrishnan, Z. Kemp, M. Gorman, I. Chandler, E. Papaemmanuil, S. Penegar, W. Wood, G. Sellick, M. Qureshi, A. Teixeira, E. Domingo, E. Barclay, L. Martin, O. Sieber, CORGI Con- sortium, D. Keer, R. Gray, J. Peto, J.B. Cazier, I. Tomlinson, and R.S. Houlston. 2007. A genome-wide asso- ciation study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet. 39(11):1315-1317. Buchet, J.P., R. Lauwerys, and H. Roels. 1981a. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48(1):71-79. Buchet, J.P., R. Lauwerys, and H. Roels. 1981b. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int. Arch. Occup. Environ. Health 48(2):111-118.

OCR for page 84
References 87 Burns, F.J., T. Rossman, K. Vega, A. Uddin, S. Vogt, B. Lai, and R.J. Reeder. 2008. Mechanisms of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice. Environ. Health Perspect. 116(6):703-708. Button, M., G.R. Jenkin, C.F. Harrington, and M.J. Watts. 2009. Human toenails as a biomarker of exposure to ele- vanted environmental arsenic. J. Environ. Monit. 11(3):610-617. Calderón, J., M.E. Navarro, M.E. Jimenez-Capdeville, M.A. Santos-Diaz, A. Golden, I. Rodriguez-Leyva, V. Borja- Aburto, and F. Díaz-Barriga. 2001. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ. Res. 85(2):69-76. Calderon, R.L., E. Hudgens, X.C. Le, D. Schreinemachers, and D.J. Thomas. 1999. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ. Health Perspect. 107(8):663-667. Calderon, R.L., E.E. Hudgens, C. Carty, B. He. X.C. Le, J. Rogers, and D.J. Thomas. 2013. Biological and behavioral factors modify biomarkers of arsenic exposure in a U.S. population. Environ. Res. doi: 10.1016/j.envres. 2013.04.004. Calleja-Agius, J., and M.P. Brincat. 2008. Recurrent miscarriages: What is the role of cytokines? Gynecol. Endocrinol. 24(12):663-668. Cantor, K.P. 2013. Strengths and Weaknesses of Recent Epidemiologic Studies of Inorganic Arsenic: Cancer Evi- dence. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Carmichael, N., M. Bausen, A.R. Boobis, S.M. Cohen, M. Embry, C. Fruijtier-Pölloth, H. Greim, R. Lewis, M.E. Meek, H. Mellor, C. Vickers, and J. Doe. 2011. Using mode of action information to improve regulatory deci- sion-making: An ECETOC/ILSI RF/HESI workshop overview. Crit. Rev. Toxicol. 41(3):175-186. Celik, I., L. Gallicchio, K. Boyd, T.K. Lam, G. Matanoski, X. Tao, M. Shiels, E. Hammond, L. Chen, K.A. Robinson, L.E. Caulfield, J.G. Herman, E. Guallar, and A.J. Alberg. 2008. Arsenic in drinking water and lung cancer: A systematic review. Environ. Res. 108(1):48-55. Chattopadhyay, S., S. Ghosh, S. Chaki, J. Debnath, and D. Ghosh. 1999. Effect of sodium arsenite on plasma levels of gonadotrophis and ovarian steroidogenesis in mature albino rats: Duration-dependent response. J. Toxi- col. Sci. 24(5):425-431. Chattopadhyay, S., S. Bhaumik, M. Purkayastha, S. Basu, A. Nag Chaudhuri, and S. Das Gupta. 2002a. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol. Let. 136(1):65-76. Chattopadhyay, S., S. Bhaumik, A. Nag Chaudhury, and S. Das Gupta. 2002b. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol. Lett. 128(1-3):73-84. Chaudhuri, A.N., S. Basu, S. Chattopadhyay, and S. Das Gupta. 1999. Effect of high arsenic content in drinking water on rat brain. Indian J. Biochem. Biophys. 36(1):51-54. Chen, B., J. Liu, Q. Chang, K. Beezhold, Y. Lu, and F. Chen. 2012. JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle 12(1):112-121. Chen, C.J., and C.J. Wang. 1990. Ecological correlation between arsenic level in well water and age-adjusted mor- tality from malignant neoplasms. Cancer Res. 50(17):5470-5474. Chen, C.J., Y.C. Chuang, T.M. Lin, and H.Y. Wu. 1985. Malignant neoplasms among residents of a blackfoot dis- ease-endemic area in Taiwan: High-arsenic artesian well water and cancer. Cancer Res. 45(11 Pt. 2):5895- 5899. Chen, C.J., Y.C. Chuang, S.L. You, T.M. Lin, and H.Y. Wu. 1986. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 53(3):399-405. Chen, C.J., C.W. Chen, M.M. Wu, and T.L. Kuo. 1992. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66(5):888-892. Chen, C.J., L.I. Hsu, C.H. Wang, W.L. Shih, Y.H. Hsu, M.P. Tseng, Y.C. Lin, W.L. Chou, C.Y. Chen, C.Y. Lee, L.H. Wang, Y.C. Cheng, C.L. Chen, S.Y. Chen, Y.H. Wang, Y.M. Hsueh, H.Y. Chiou, and M.M. Wu. 2005. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol. Appl. Pharmacol. 206(2):198-206. Chen, C.J., S.L. Wang, J.M. Chiou, C.H. Tseng, H.Y. Chiou, Y.M. Hsueh, S.Y. Chen, M.M. Wu, and M.S. Lai. 2007. Arsenic and diabetes and hypertension in human populations: A review. Toxicol. Appl. Pharmacol. 222(3):298-304. Chen, C.L., L.I. Hsu, H.Y. Chiou, Y.M. Hsueh, S.Y. Chen, M.M. Wu, and C.J. Chen. 2004. Ingested arsenic, ciga- rette smoking, and lung cancer: A follow-up study in arseniasis-endemic areas in Taiwan. JAMA 292(24):2984-2990.

OCR for page 84
88 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Chen, C.L., H.Y. Chiou, L.I. Hsu, Y.M. Hsueh, M.M. Wu, Y.H. Wang, and C.J. Chen. 2010. Arsenic in drinking water and risk of urinary tract cancer: A follow-up study from northeastern Taiwan. Cancer Epidemiol. Bi- omarkers Prev. 19(1):101-110. Chen, G.C., L.S. Guan, W.L. Hu, and Z.Y. Wang. 2002. Functional repression of estrogen receptor by arsenic triox- ide in human breast cancer cells. Anticancer Res. 22(2A):633-638. Chen, J.W., H.Y. Chen, W.F. Li, S.H. Liou, C.J. Chen, J.H. Wu, and S.L. Wang. 2011. The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan. Chemosphere 84(1):17-24. Chen, Y., J.H. Graziano, F. Parvez, I. Hussain, H. Momotaj, A. van Geen, G.R. Howe, and H. Ahsan. 2006. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 17(4):459-467. Chen, Y., M. Hall, J.H. Graziano, V. Slavkovich, A. van Geen, F. Parvez, and H. Ahsan. 2007a. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Bi- omarkers Prev. 16(2):207-213. Chen, Y., P. Factor-Litvak, G.R. Howe, J.H. Graziano, P. Brandt-Rauf, F. Parvez, A. van Geen, and H. Ahsan. 2007b. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pres- sure in Bangladesh: A population-based, cross-sectional study. Am. J. Epidemiol. 165(5):541-552. Chen, Y., R.M. Santella, M.G. Kibriya, Q. Wang, M. Kappil, W.J. Verret, J.H. Graziano, and H. Ahsan. 2007c. As- sociation between arsenic exposure from drinking water and plasma levels of soluble cell adhesion mole- cules. Environ. Health Perspect. 115(10):1415-1420. Chen, Y., J.H. Graziano, F. Parvez, M. Liu, V. Slavkovich, T. Kalra, M. Argos, T. Islam, A. Ahmed, M. Rakibuz- Zaman, R. Hasan, G. Sarwar, D. Levy, A. van Geen, and H. Ahsan. 2011a. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: Prospective cohort study. BMJ 342:d2431. Chen, Y., F. Parvez, M. Liu, G.R. Pesola, M.V. Gamble, V. Slavkovich, T. Islam, A. Ahmed, R. Hasan, J.H. Grazi- ano, and H. Ahsan. 2011b. Association between arsenic exposure from drinking water and proteinuria: Re- sults from the Health Effects of Arsenic Longitudinal Study. Int. J. Epidemiol. 40(3):828-835. Chen, Y.C., Y.L. Guo, H.J. Su, Y.M. Hsueh, T.J. Smith, L.M. Ryan, M.S. Lee, S.C. Chao, J.Y. Lee, and D.C. Chris- tiani. 2003. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45(3):241-248. Cherry, N., K. Shaikh, C. McDonald, and Z. Chowdhury. 2008. Stillbirth in rural Bangladesh: Arsenic exposure and other etiological factors: Report from Gonoshasthaya Kendra. Bull. World Health Organ. 86(3):172-177. Chiang, H.C., and T.C. Tsou. 2009. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Toxicol. In Vitro 23(5):897-905. Chiu, H.F., and C.Y. Yang. 2005. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan. J. Toxicol. Environ. Health A 68(5):319-327. Chou, T.C., and P. Talalay. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55. Chung, C.J., Y.S. Pu, C.T. Su, C.Y. Huang, and Y.M. Hsueh. 2011. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Sci. Total Environ. 409(3):465- 470. Chung, C.J., C.Y. Huang, Y.S. Pu, H.S. Shiue, C.T. Su, and Y.M. Hsueh. 2013. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null geno- type. Toxicol. Appl. Pharmacol. 266(2):254-259. Clewell, H. 2013. Extrapolation of Mode of Action Data to Dose-Response Modeling of Human Health Endpoints. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Clewell, H.J., R.S. Thomas, E.M. Kenyon, M.F. Hughes, B.M. Adair, P.R. Gentry, and J.W. Yager. 2011. Concen- tration- and time-dependent genomic changes in the mouse urinary bladder following exposure to arsenate in drinking water for up to 12 weeks. Toxicol. Sci. 123(2):421-432. Cohen, S.M. 2013. Mode of Action and Mechanism: Identification and Implications for Low Dose Assessments. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Combs, G.F., Jr. 2001. Selenium in global food systems. Br. J. Nutr. 85(5):517-547. Concha, G., G. Vogler, D. Lezcano, B. Nermell, and M. Vahter. 1998a. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44(2):185-190.

OCR for page 84
References 89 Concha, G., G. Vogler, B. Nermell, and M. Vahter. 1998b. Low-level arsenic excretion in breast milk of native An- dean women exposed to high levels of arsenic in the drinking water. Int. Arch. Occup. Environ. Health 71(1):42-46. Consumer Reports. 2012a. Arsenic in Your Juice. Consumer Reports Magazine (January):22-27 [online]. Available: http://www.consumerreports.org/cro/magazine/2012/01/arsenic-in-your-juice/index.htm [accessed May 20, 2013]. Consumer Reports. 2012b. Arsenic in Your Food. Consumer Reports Magazine (November):22-27 [online]. Available: http://www.consumerreports.org/cro/magazine/2012/11/arsenic-in-your-food/index.htm [accessed May 20, 2013]. Coronado-Gonzalez, J.A., L.M. Del Razo, G. Garcia-Vargas, F. Sanmiguel-Salazar, and P.J. Escobedo-de la Pena. 2007. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ. Res. 104(3):383-389. Cronican, A.A., N.F. Fitz, A. Carter, M. Saleem, S. Shiva, A. Barchowsky, R. Koldamova, J. Schug, and I. Lefterov. 2013. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS One 8(2):e53478. Cupples, L.A., H.T. Arruda, E.J. Benjamin, R.B. D'Agostino, Sr., S. Demissie, A.L. DeStefano, J. Dupuis, K.M. Falls, C.S. Fox, D.J. Gottlieb, D.R. Govindaraju, C.Y. Guo, N.L. Heard-Costa, S.J. Hwang, S. Kathiresan, D.P. Kiel, J.M. Laramie, M.G. Larson, D. Levy, C.Y. Liu, K.L. Lunetta, M.D. Mailman, A.K. Manning, J.B. Meigs, J.M. Murabito, C. Newton-Cheh, G.T. O'Connor, C.J. O'Donnell, M. Pandey, S. Seshadri, R.S. Vasan, Z.Y. Wang, J.B. Wilk, P.A. Wolf, Q. Yang, and L.D. Atwood. 2007. The Framingham Heart Study 100K SNP ge- nome-wide association study resource: Overview of 17 phenotype working group reports. BMC Med. Genet. 8(suppl. 1):S1. Currier, J.M., R.J. Saunders, L. Ding, W. Bodnar, P. Cable, T. Matousek, J.T. Creed, and M. Styblo. 2013. Compar- ative oxidation state specific analysis of arsenic species by high-performance liquid chromatography- inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry. J. Anal. Atom. Spectrom. 28(6):843-852. Dakeishi, M., K. Murata, and P. Grandjean. 2006. Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ. Health 5:21. Dani, S.U. 2013. Osteoresorptive arsenic intoxication. Bone 53(2):541-545. Das, N., S. Paul, D. Chatterjee, N. Banerjee, N.S. Majumder, N. Sarma, T.J. Sau, S. Basu, S. Banerjee, P. Majum- der, A.K. Bandyopadhyay, J.C. States, and A.K. Giri. 2012. Arsenic exposure through drinking water in- creases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health 12:639. Dauphine, D.C., C. Ferreccio, S. Guntur, S.K. Hammond, J. Balmes, A.H. Smith, and C. Steinmaus. 2011. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: Preliminary findings. Int. Arch. Occup. Environ. Health 84(6):591-600. Davey, J.C., J.E. Bodwell, J.A. Gosse, and J.W. Hamilton. 2007. Arsenic as an endocrine disruptor: Effects of arse- nic on estrogen receptor-mediated gene expression in vivo and cell culture. Toxicol. Sci. 98(1):75-86. Davey, J.C., A.P. Nomikos, M. Wungjiranirun, J.R. Sherman, L. Ingram, C. Batki, J.P. Lariviere, and J.W. Hamil- ton. 2008. Arsenic as an endocrine disruptor: Arsenic disrupts retinoic acid receptor- and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ. Health Perspect. 116(2):165-172. Davis, M.A., T.A. Mackenzie, K.L. Cottingham, D. Gilbert-Diamond, T. Punshon, and M.R. Karagas. 2012. Rice consumption and urinary arsenic concentrations in U.S. children. Environ. Health Perspect. 120(10):1418- 1424. De, B.K., D. Majumdar, S. Sen, S. Guru, and S. Kundu. 2004. Pulmonary involvement in chronic arsenic poisoning from drinking contaminated ground-water. J. Assoc. Physicians India 52:395-400. Del Razo, L.M., G.G. Garcia-Vargas, O.L. Valenzuela, E.H. Castellanos, L.C. Sanchez-Pena, J.M. Currier, Z. Drobna, D. Loomis, and M. Styblo. 2011. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ. Health 10:73. Devesa, V., B.M. Adair, J. Liu, M.P. Waalkes, B.A. Diwan, M. Styblo, and D.J. Thomas. 2006. Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 224(1-2):147-155. Diaz-Villasenor, A., A.L. Burns, M. Hiriart, M.E. Cebrian, and P. Ostrosky-Wegman. 2007. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol. Appl. Pharmacol. 225(2):123-133. Dickersin, K. 2002. Systematic reviews in epidemiology: Why are we so far behind? Int. I. Epidemiol. 31(1):6-12. Dietert, R.R. 2009. Developmental immunotoxicology: Focus on health risks. Chem. Res. Toxicol. 22(1): 17-23.

OCR for page 84
90 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Dietert, R.R. 2011. Rold of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod. Toxicol. 31(3):319-226. Dietert, R.R., and J.T. Zelikoff. 2008. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res. B Dev. Reprod. Toxicol. 83(6):547-560. Dong, Z. 2002. The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ. Health Perspect. 110 (suppl. 5):757-759. Dopp, E., U. von Recklinghausen, R. Diaz-Bone, A.V. Hirner, and A.W. Rettenmeier. 2010. Cellular uptake, subcel- lular distribution and toxicity of arsenic compounds in methylating and non-methylating cells. Environ. Res. 110:435-442. Drobna, Z., L.M. Del Razo, G.G. Garcia-Vargas, L.C. Sanchez-Pena, A. Barrera-Hernandez, M. Styblo, and D. Loomis. 2013. Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico. J. Expo. Sci.Environ. Epidemiol. 23(2):151-155. Drobna, Z., H. Naranmandura, K.M. Kubachka, B.C. Edwards, K. Herbin-Davis, M. Styblo, X.C. Le, J.T. Creed, N. Maeda, M.F. Hughes, and D.J. Thomas. 2009. Disruption of the arsenic (+3 oxidation state) methyltrans- ferase gene in mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22(10):1713-1720. Du, J., N. Zhou, H. Liu, F. Jiang, Y. Wang, C. Hu, H. Qi, C. Zhong, X. Wang, and Z. Li. 2012. Arsenic induces functional re-expression of estrogen receptor alpha by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One 7(4):e35957. Ebert, F. A. Weiss, M. Bültemeyer, I. Hamann, A. Hartwig, and T. Schwerdtle. 2011. Arsenicals affect base exci- sion repair by several mechanisms. Mutat. Res. 715(1-2):32-41. EFSA (European Food Safety Authority). 2009. Scientific Opionion on Arsenic in Food. EFSA Journal 7(10):1351 [online]. Available: http://www.efsa.europa.eu/en/scdocs/doc/1351.pdf [accessed May 22, 2013]. Egger, M., G.D. Smith, and J.A. Sterne. 2001. Uses and abuses of meta-analysis. Clin. Med. 1(6):478-484. El-Masri, H.A., and E.M. Kenyon. 2008. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites. J. Pharmacokinet. Pharmacodyn. 35(1):31-68. Engström, K., M. Vahter, S.J. Mlakar, G. Concha, B. Nermell, R. Ragib, A. Cardozo, and K. Broberg. 2011. Poly- morphisms in arsenic (+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ. Health Perspect. 119(2):182-188. Engström, K.S., M.B. Hossain, M. Lauss, S. Ahmed, R. Ragib, M. Vahter, and K. Broberg. 2013. Efficient arsenic metabolism—the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS One 8(1):e53732. Eom, S.Y., Y.C. Lee, D.H. Yim, C.H. Lee, Y.D. Kim, B.S. Choi, C.H. Park, S.D. Yu, D.S. Kim, J.D. Park, and H. Kim. 2011. Effects of low-level arsenic exposure on urinary N-acetyl-beta-D-glucosaminidase activity. Hum. Exp. Toxicol. 30(12):1885-1891. EPA (U.S. Environmental Protection Agency). 2001. Toxicological Review of Chloroform (CAS No. 67-66-3) in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635/R-01/001. U.S. Environmental Protection Agency, Washington, DC [online]. Available: http://www.epa.gov/iris/tox reviews/0025tr.pdf [accessed July 17, 2013]. EPA (U.S. Environmental Protection Agency). 2005a. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC [online]. Available: http://www.epa.gov/ttnatw01/childrens_supple ment_final.pdf [accessed May 20, 2013]. EPA (U.S. Environmental Protection Agency). 2005b. Guidelines for Carcinogen Risk Assessment. EPA/630/P- 03/001B. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. March 2005 [online]. Available: http://www.epa.gov/raf/publications/pdfs/CANCER_GUIDELINES_FINAL_3-25-05.PDF [accessed May 20, 2013]. EPA (U.S. Environmental Protection Agency). 2011. Toxicological Review of Trichloroethylene (CAS No. 71-09- 6) in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635/R- 09/011F. U.S. Environmental Protection Agency, Washington, DC [online]. Available: http://www.epa. gov/iris/toxreviews/0199tr/Intro_0199tr.pdf [accessed July 17, 2013]. EPA (U.S. Environmental Protection Agency). 2012. Benchmark Dose Technical Guidance. EPA/100/R-12/001. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC [online]. Available: http:// www.epa.gov/osa/raf/publications/benchmark_dose_guidance.pdf [accessed July 3, 2013].

OCR for page 84
References 91 EPA (U.S. Environmental Protection Agency). 2013a. Part 1. Status of Implementation of Recommendations. Mate- rials Submitted to the National Research Council, by Integrated Risk Information System Program, U.S. Environmental Protection Agency, January 30, 2013. EPA (U.S. Environmental Protection Agency). 2013b. Part 2. Chemical-Specific Examples. Materials Submitted to the National Research Council, by Integrated Risk Information System Program, U.S. Environmental Pro- tection Agency, January 30, 2013. EPA (U.S. Environmental Protection Agency). 2013c. Draft Assessment Development Plan for the Toxicological Review of Inorganic Arsenic. Submitted to the National Research Council, by Integrated Risk Information System Program, U.S. Environmental Protection Agency, May 22, 2013. EPA (U.S. Environmental Protecton Agency). 2013d. Draft Supporting Documents for the Development of the In- organic Arsenic Toxicological Review. Submitted to the National Research Council, by Integrated Risk In- formation System Program, U.S. Environmental Protection Agency, May 22, 2013. EPA (U.S. Environmental Protection Agency). 2013e. National Priorities List (NPL) [online]. Available: http://www. epa.gov/superfund/sites/npl/ [accessed June 27, 2013]. EPA (U.S. Environmental Protection Agency). 2013f. Superfund Site Information [online]. Available: http://www. cumulis.epa.gov/supercpad/cursites/srchsites.cfm [accessed June 27, 2013]. EPASAB (U.S. Environmental Protection Agency, Science Advisory Board). 2007. Advisory on EPA’s Assessments of Carcinogenic Effects of Organic and Inorganic Arsenic: A report of the US EPA Science Advisory Board. EPA-SAB-07-008. Memo to Stephen I. Johnson, Administrator, from M. Granger Morgan, Chair, Science Advisory Board, and Genevieve Matanoski, Chair, Science Advisory Board Arsenic Review Panel, U.S. En- vironmental Protection Agency, Washington, DC. June 28, 2007 [online]. Available: http://cfpub.epa. gov/ncea/iris_drafts/recordisplay.cfm?deid=219106 [access Mar. 4, 2013]. EPASAB (U.S. Environmental Protection Agency, Science Advisory Board). 2011. Review Comments on EPA’s Re- sponsiveness to SAB 2007 Recommendations for the Revision of Cancer Assessment of Inorganic Arsenic. Memo to Lisa P. Jackson, Administrator, U.S. Environmental Protection Agency, from Deborah L. Swack- hamer, Chair, Science Advisory Board, and Elaine Faustman, Chair, SAB Arsenic Cancer Workgroup, U.S. Environmental Protection Agency, Washington, DC. March 1, 2011 [online]. Available: http://yosemite.epa. gov/sab/sabproduct.nsf/9FCEE4E20ABD6EB48525784600791AC2/$File/EPA-SAB-11-003-unsigned.pdf [access Mar. 4, 2013]. Ettinger, A.E., A.R. Zota, C.J. Amarasiriwardena, M.R. Hopkins, J. Schwartz, H. Hu, and R.O. Wright. 2009. Maternal arsenic exposure and impaired glucose tolerance during pregnancy. Environ. Health Perspect. 117(7):1059- 1064. Fangstrom, B., S. Moore, B. Nermell, L. Kuenstl, W. Goessler, M. Grander, I. Kabir, B. Palm, S.E. Airfeen, and M. Vahter. 2008. Breast-feeding protects against arsenic exposure in Bangladeshi infants. Environ. Health Per- spect. 116(7):963-969. Farber, E.M. 1992. History of the treatment of psoriasis. J. Am. Acad. Dermatol. 27(4):640-645. Farzan, S., S. Korrick, Z. Li, R. Enelowa, A.J. Gandolfi, J. Madan, K. Nadeau, and M. Karagas. 2013. In utero arse- nic exposure and infant infection in a United States cohort: A prospective study. Environ. Res. doi: 10.1016/j.envres.2013.05.001. Ferreccio, C., C. Gonzalez, V. Milosavljevic, G. Marshall, A.M. Sancha, and A.H. Smith. 2000. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11(6):673-679. Ferreccio, C., A.H. Smith, V. Durán, T. Barlaro, H. Benítez, R. Valdés, J.J. Aguirre, L.E. Moore, J. Acevedo, M.I. Vásquez, L. Pérez, Y. Yuan, J. Liaw, K.P. Cantor, and C. Steinmaus. 2013. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed northern Chile. Am. J. Epidemiol. doi: 10.1093/aje/ kwt059. Fischer, J.M., S.B. Robbins, M. Al-Zoughool, S.S. Kannamkumarath, S.L. Stringer, J.S. Larson, J.A. Caruso, G. Talaska, P.J. Stambrook, and J.R. Stringer. 2005. Co-mutagenic activity of arsenic and benzo[a]pyrene in mouse skin. Mutat. Res. 588(1):35-46. Flora, S.J., S.C. Pant, P.R. Malhotra, and G.M. Kannan. 1997. Biochemical and histopathological changes in arse- nic-intoxicated rats coexposed to ethanol. Alcohol 14(6):563-568. Flores-Mateo, G., A. Navas-Acien, R. Pastor-Barriuso, and E. Gullar. 2006. Selenium and coronary heart disease: A meta-analysis. Am. J. Clin. Nutr. 84(4):762-773. Fricke, M.W., M. Zeller, H. Sun, W.R. Cullen, J.A. Shoemaker, M.R. Witkowski, and J.T. Creed. 2005. Chromato- graphic separation and identification of products from the reaction of dimethylarsinic acid with hydrogen sulfide. Chem. Res. Toxicol. 18(12):1821-1829.

OCR for page 84
92 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Fry, R.C., C. Navasumrit, C. Valiathan, J.P. Svensson, B.J. Hogan, M. Luo, K. Bhattacharya, S. Kandjanapa, S. Soontararuks, S. Nookabkaew, C. Mahidol, M. Ruchirawat, and L.D. Samson. 2007. Activation of inflam- mation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 3(11):e207. Gailer, J., G.N. George, I.J. Pickering, R.C. Prince, H.S. Younis, and J.J. Winzerling. 2002. Biliary excretion of [(GS)(2)AsSe](-) after intravenous injection of rabbits with arsenite and selenite. Chem. Res. Toxicol. 15(11):1466-1471. Gamble, M.V. 2013. Interplay between One-Carbon Metabolism, Arsenic Metabolism and Epigenetics. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Gamble, M.V., X. Liu, H. Ahsan, R. Pilsner, V. Ilievski, V. Slavkovic, F. Parvez, D. Levy, P. Factor-Litvak, and J.H. Graziano. 2005. Folate, homocysteine and arsenic metabolism in arsenic-exposed individuals in Bang- ladesh. Environ. Health Perspect. 113(12):1683-1688. Gamble, M.V., X. Liu, V. Slavkovich, J.R. Pilsner, V. Ilievski, P. Factor-Litvak, D. Levy, S. Alam, M. Islam, F. Parvez, H. Ahsan, and J. Graziano. 2007. Folic acid supplementation lowers blood arsenic. Am. J. Clin. Nutr. 86(4):1202-1209. Gandhi, D.N., G.M. Panchal, and K.G. Patel. 2012. Developmental and neurobehavioural toxicity study of arsenic on rats following gestational exposure. Indian J. Exp. Biol. 50(2):147-155. Gao, N., L. Shen, Z. Zhang, S.S. Leonard, H. He, X.G. Zhang, X. Shi, and B.H. Jiang. 2004. Arsenite induces HIF- 1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell Biochem. 255(1-2):33-45. Garber, M., M.G. Grabherr, M. Guttman, and c. Trapnell. 2011. Computational methods for transcriptome annota- tion and quantification using RNA-seq. Nat. Methods 8(6):469-477. Garcia-Esquinas, E., M. Pollan, J.G. Umans, K.A. Francesconi, W. Goessler, E. Guallar, B. Howard, J. Farley, J. Yeh, L.G. Best, and A. Navas-Acien. In press. Arsenic exposure and cancer mortality in a US-based pro- spective cohort: The Strong Heart Study. Cancer Epidemiol. Biomarkers Prev. Gardner, R.M., B. Nermell, M. Kippler, M. Grandér, L. Li, E.C. Ekström, A. Rahman, B. Lönnerdal, A.M. Hoque, and M. Vahter. 2011. Arsenic methylation efficiency increases during the first trimester of pregnancy inde- pendent of folate status. Reprod. Toxicol. 31(2):210-218. Gardner, R.M., M. Kippler, F. Tofail, M. Bottai, J. Hamadani, M. Grander, B. Nermell, B. Palm, K.M. Rasmussen, and M. Vahter. 2013. Environmental exposure to metals and children’s growth to age 5 years: A prospec- tive cohort study. Am. J. Epidemiol. 177(12):1356-1367. Garland, M., J.S. Morris, B.A. Rosner, M.J. Stampfer, V.L. Spate, C.J. Baskett, W.C. Willett, and D.J. Hunter. 1993. Toenail trace element levels as biomarkers: Reproducibility over a 6-year period. Cancer Epidemiol. Bi- omarkers Prev. 2(5):493-497. Geneletti, S., V. Gallo, M. Porta, M.J. Khoury, and P. Vineis. 2011. Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs. Emerg. Themes Epidemiol. 8(1):5 doi: 10.1186/1742-7622-8-5. Gentry, P.R., T.B. McDonald, D.E. Sullivan, A.M. Shipp, J.W. Yager, and H.J. Clewell, III. 2010. Analysis of ge- nomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Mol. Mutagen. 51(1):1-14. Ghosh, P., M. Banerjee, S. De Chaudhuri, R. Chowdhury, J.K. Das, A. Mukherjee, A.K. Sarkar, L. Mondal, K. Baidya, T.J. Sau, A. Banerjee, A. Basu, K. Chaudhuri, K. Ray, and A.K. Giri. 2007. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J. Expo. Sci. Environ. Epidemiol. 17(3):215-223. Gilbert-Diamond, D., K.L. Cottingham, J.F. Gruber, T. Punshon, V. Sayarath, A.J. Gandolfi, E.R. Baker, B.P. Jack- son, C.L. Folt, and M.R. Karagas. 2011. Rice consumption contributes to arsenic exposure in U.S. women. Proc. Natl. Acad. Sci. USA 108(51):20656-20660. Gilbert-Diamond, D., Z. Li, A.E. Perry, S.K. Spencer, A.J. Gandolfi, and M.R. Karagas. 2013. A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Envi- ron. Health Perspect. doi:10.1289/ehp.1206178. Ginsberg, G.L. 2012. Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 75(7):374-390. Ginsberg, J.M. 1965. Renal mechanism for excretion and transformation of arsenic in the dog. Am. J. Physiol. 208: 832-840. Ginsberg, J.M., and W.D. Lotspeich. 1963. Interrelations of arsenate and phosphate transport in the dog kidney. Am. J. Physiol. 205:707-714.

OCR for page 84
References 93 Goggin, S.L., M.T. Labrecque, and A.M. Allan. 2012. Perinatal exposure to 50 ppb sodium arsenate induces hypo- thalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology 33(5):1338-1345. Gomez-Rubio, P., Y.C. Klimentidis, E. Cantu-Soto, M.M. Meza-Montenegro, D. Billheimer, Z. Lu, Z. Chen, and W.T. Klimecki. 2012. Indigenous American ancestry is associated with arsenic methylation efficiency in an admixed population of northwest Mexico. J. Toxicol. Environ. Health A 75(1):36-49. Gorby, M.S. 1994. Arsenic in human medicine. Pp. 1-16 in Arsenic in the Environment, Part II. Human Health and Ecosystem Effects, J.O. Nriagu, ed. New York: Wiley Interscience. Grahame, T.J., and R.B. Schlesinger. 2012. Oxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular disease. Part. Fibre Toxicol. 9:21. Greenland, S., and M.P. Longnecker. 1992. Methods for trend estimation from summarized dose-response data, with application to meta-analysis. Am. J. Epidemiol. 135(11):1301-1309. Gribble, M.O., B.V. Howard, J.G. Umans, N.M. Shara, K.A. Francesconi, W. Goessler, C.M. Crainiceanu, E.K. Silbergeld, E. Guallar, and A. Navas-Acien. 2012. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am. J. Epidemiol. 176(10):865-874. Grosse, S.D., T.D. Matte, J. Schwartz, and R.J. Jackson. 2002. Economic gains resulting from the reduction in chil- dren's exposure to lead in the United States. Environ. Health Perspect. 110(6):563-569. Guha Mazumder, D.N. 2003. Chronic arsenic toxicity: Clinical features, epidemiology, and treatment: Experience in West Bengal. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 38(1):141-163. Gul Kazi, T., A. Qadir Shah, H. Imran Afridi, N. Ali Shah, and M. Balal Arain. 2013. Hazardous impact of organic arsenical compounds in chicken feed on different tissues of broiler chicken and manure. Ecotoxicol. Envi- ron. Saf. 87:120-123. Guo, H.R. 2003. The lack of a specific association between arsenic in drinking water and hepatocellular carcinoma. J. Hepatol. 39(3):383-388. Guo, H.R. 2004. Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Causes Control 15(2):171-177. Guo, X., Y. Fujino, X. Ye, J. Liu, and T. Yoshimura. 2006. Association between multi-level inorganic arsenic exposure from drinking water and skin lesions in China. Int. J. Environ. Res. Public Health 3(3):262-267. Haines, J.L., N. Schnetz- Boutaud, S. Schmidt, W.K. Scott, A. Agarwal, E.A. Postel, L. Olson, S.J. Kenealy, M. Hauser, J.R. Gilbert, and M.A. Pericak-Vance. 2006. Functional candidate genes in age-related macular de- generation: Significant association with VEGF, VLDLR, and LRP6. Invest. Ophthalmol. Vis. Sci. 47(1):329- 335. Hall, M., Y. Chen, H. Ahsan, V. Slavkovich, A. van Geen, F. Parvez, and J. Graziano. 2006. Blood arsenic as a bi- omarker of arsenic exposure: Results from a prospective study. Toxicology 225(2-3):225-233. Hall, M., M. Gamble, V. Slavkovich, X. Liu, D. Levy, Z. Cheng, A. van Geen, M. Yunus, M. Rahman, J.R. Pilsner, and J. Graziano. 2007. Determinants of arsenic metabolism: Blood arsenic metabolites, plasma folate, cobal- amin, and homocysteine concentrations in maternal-newborn pairs. Environ. Health Perspect. 115(10):1503- 1509. Hall, M.N., and M.V. Gamble. 2012. Nutritional manipulation of one-carbon metabolism: Effects on arsenic meth- ylation and toxicity. J. Toxicol. (2012):Art. 595307. Hamadani, J.D., S.M. Grantham-McGregor, F. Tofail, B. Nermell, B. Fängström, S.N. Huda, S. Yesmin, M. Rah- man, M. Vera-Hernández, S.E. Arifeen, and M. Vahter. 2010. Pre- and postnatal arsenic exposure and child development at 18 months of age: A cohort study in rural Bangladesh. Int. J. Epidemiol. 39(5):1206-1216. Hamadani, J.D., F. Tofail, B. Nermell, R. Gardner, S. Shiraji, M. Bottai, S.E. Arifeen, S.N. Huda, and M. Vahter. 2011. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: A population-based cohort study. Int. J. Epidemiol. 40(6):1593-1604. Hansen, K.D., R.A. Irizarry, and Z. Wu. 2012. Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics 13(2):201-216. Hansen, M. 2013. Aspects of the Toxicological Review of Inorganic Arsenic Critical for Maximizing its Utility and Credibility for Public Interest Risk Assessments. Presentation at the Workshop- Inorganic Arsenic: Scien- tific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Haque, R., D.N. Mazumder, S. Samanta, N. Ghosh, D. Kalman, M.M. Smith, S. Mitra, A. Santra, S. Lahiri, S. Das, D.K. De, and A.H. Smith. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14(2):174-182. Harari, F., K. Engström, G. Concha, G. Colque, M. Vahter, and K. Broberg. 2013. N-6-Adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women. Environ. Health Perspect. 121(7):797-803.

OCR for page 84
94 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Hartwig, A. 2013. Metal interaction with redox regulation: An integrating concept in metal carcinogenesis? Free Radic. Biol. Med. 55:63-72. Hays, A.M., R.C. Lantz, L.S. Rodgers, J.J. Sollome, R.R. Vaillancourt, A.S. Andrew, J.W. Hamilton, and T.D. Camenisch. 2008. Arsenic-induced decreases in the vascular matrix. Toxicol. Pathol. 36(6):805-817. He, Y., and Y. Zheng. 2010. Assessment of the in vivo bioaccessibility of arsenic in dietary rice by mass balance. Sci. Tot. Environ. 408(6):1430-1436. Heck, J.E., A.S. Andrew, T. Onega, J.R. Rigas, B.P. Jackson, M.R. Karagas, and E.J. Duell. 2009a. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 117(111):1718-1723. Heck, J.E., J.W. Nieves, Y. Chen, F. Parvez, P.W. Brandt-Rauf, J.H. Graziano, V. Slavkovich, G.R. Howe, and H. Ahsan. 2009b. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangla- desh. Environ. Health Perspect. 117:99-104. Heilmann, C., P. Grandjean, P. Weihe, F. Nielsen, and E. Budtz-Jørgensen. 2006. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med. 3(8):e311. Hertz-Picciotto, I., A.H. Smith, D. Holtzman, M. Lipsett, and G. Alexeeff. 1992. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology 3(1):23-31. Hill, D.S., B.J. Wlodarczyk, and R.H. Finnell. 2008. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res. B. Dev. Reprod. Toxicol. 83(1):40-47. Hinwood, A.L., D.J. Jolley, and M.R. Sim. 1999. Cancer incidence and high environmental arsenic concentrations in rural populations: Results of an ecological study. Int. J. Environ. Health Res. 9(2):131-141. Hirschhorn, J.N. 2005. Genetic approaches to studying common diseases and complex traits. Pediatr. Res. 57(5 Pt. 2):74R-77R. Hirschhorn, J.N., and M.J. Daly. 2005. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6(2):95-108. Hong, F., T. Jin, and A. Zhang. 2004. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 17(5):573-580. Hopenhayn, C., B. Huang, J. Christian, C. Peralta, C. Ferreccio, R. Atallah, and D. Kalman. 2003. Profile of urinary arsenic metabolites during pregnancy. Environ. Health Perspect. 111(16):1888-1891. Hopenhayn, C., C. Ferreccio, S.R. Browning, B. Huang, C. Peralta, H. Gibb, and I. Hertz-Picciotto. 2003b. Arsenic exposure from drinking water and birth weight. Epidemiology 14(5):593-602. Hopenhayn-Rich, C., A.H. Smith, and H.M. Goeden. 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60(2):161-177. Hopenhayn-Rich, C., M.L. Biggs, A.H. Smith, D.A. Kalman, and L.E. Moore. 1996. Methylation study of a popula- tion environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 104(6):620-628. Hopenhayn-Rich, C., M.L. Biggs, and A.H. Smith. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27(4):561-569. Hopenhayn-Rich, C., S.R. Browning, I. Hertz-Picciotto, C. Ferreccio, C. Peralta, and H. Gibb. 2000. Chronic arsenic exposure and risk of infant mortality in tow areas of Chile. Environ. Health Perspect. 108(7):667-673. Hore, S.K., M. Rahman, M. Yunus, C.S. Das, S. Yeasmin, S.K. Ahmad, M.H. Sayed, A.M. Islam, M. Vahter, and L.A. Persson. 2007. Detecting arsenic-related skin lesions: Experiences from a large community-based survey in Bangladesh. Int. J. Environ. Health Res. 17(2):141-149. Hough, R.L., T. Fletcher, G.S. Leonardi, W. Goessler, T. Gnagnarella, F. Clemens, E. Gurzau, K. Koppova, P. Rud- nai, R. Kumar, and M. Vahter. 2010. Lifetime exposure to arsenic in residential drinking water in Central Europe. Int. Arch. Occup. Environ. Health 83(5):471-481. Hsieh, Y.C., L.M. Lien, W.T. Chung, F.I. Hsieh, P.F. Hsieh, M.M. Wu, H.P. Tseng, H.Y. Chiou, and C.J. Chen. 2011. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ. Res. 111(6):804-810. Hsu, C.Y. 2011. Epidemiology of kidney disease. Chapter 19 in Brenner and Rector’s The Kidney, Ninth Edition, M.W. Taal, G.M. Chertow, P.A. Marsden, K. Skorecki, A.S.L. Yu, and B.M. Brenner, eds. Phildelphia, PA: Elsevier Saunders. Hsu, L.I., A.W. Chiu, S.K. Huan, C.L. Chen, Y.H. Wang, F.I. Hsieh, W.L. Chou, L.H. Wang, and C.J. Chen. 2008. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transi- tional cell carcinoma in southwestern Taiwan. Toxicol. Appl. Pharmacol. 228(2):144-155. Hsu, L.I., W.P. Chen, T.Y. Yang, Y.H. Chen, W.C. Lo, Y.H. Wang, Y.T. Liao, Y.M. Hsueh, H.Y. Chiou, M.M. Wu, and C.J. Chen. 2011. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. J. Biomed. Sci. 18:51. doi: 10.1186/1423-0127-18-51.

OCR for page 84
100 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Murabito, J.M., C.L. Rosenberg, D. Finger, B.E. Kreger, D. Levy, G.L. Splansky, K. Antman, and S.J. Hwang. 2007. A genome-wide association of breast and prostate cancer in the NHLBI’s Framingham Heart Study. BMC Med. Genet. 8(suppl. 1):S6. Myers, S.L., D.T. Lobdell, Z. Liu, Y. Xia, H. Ren, Y. Li, R.K. Kwok, J.L. Mumford, and P. Mendola. 2010. Mater- nal drinking water arsenic exposure and perinatal outcomes in Inner Mongolia, China. J. Epidemiol. Com- munity Health 64(4):325-329. Nafees, A.A., A. Kazi, Z. Fatmi, M. Irfan, A. Ali, and F. Kayama. 2011. Lung function decrement with arsenic exposure to drinking groundwater along River Indus: A comparative cross-sectional study. Environ. Geochem. Health 33(2):203-216. Nagaraja, T.N., and T. Desiraju. 1993. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull. Environ. Contam. Toxicol. 50(1):100-107. Nagaraja, T.N., and T. Desiraju. 1994. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum. Exp. Toxicol. 13(5):353-356. Nascimento, M.G., S. Suzuki, M. Wei, A. Tiwari, L.L. Arnold, X. Lu, X.C. Le, and S.M. Cohen. 2008. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro. Toxicology 249(1):69-74. Nasreddine, L., and D. Parent-Massin. 2002. Food contamination by metals and pesticides in the European Union. Should we worry? Toxicol. Lett. 127(1-3):29-41. Naujokas, M.F., B. Anderson, H. Ahsan, H.V. Aposhian, J.H. Graziano, C. Thompson, and W.A. Suk. 2013. The broad scope of health effects from chronic exposure: Update on the worldwide public health problem. En- viron. Health Perspect. 121(3):295-302. Navas-Acien, A., A.R. Sharrett, E.K. Silbergeld, B.S. Schwartz, K.E. Nachman, T.A. Burke, and E. Guallar. 2005. Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162(11):1037-1049. Navas-Acien, A., E.K. Silbergeld, R.A. Streeter, J.M. Clark, T.A. Burke, and E. Guallar. 2006. Arsenic exposure and type 2 diabetes: A systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 114(5):641-648. Navas-Acien, A., E.K. Silbergeld, R. Pastor-Barriuso, and E. Guallar. 2008. Arsenic exposure and prevalence of type 2 diabetes in U.S. adults. JAMA 300(7):814-822. Navas-Acien, A., E.K. Silbergeld, R. Pastor-Barriuso, and E. Guallar. 2009a. Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: Updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology 20(6):816-820. Navas-Acien, A., J.G. Umans, B.V. Howard, W. Goessler, K.A. Francesconi, C.M. Crainiceanu, E.K. Silbergeld, and E. Guallar. 2009b. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: The Strong Heart Study. Environ. Health Perspect. 117(9):1428-1433. Navas-Acien, A., K.A. Francesconi, E.K. Silbergeld, and E. Guallar. 2011. Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the U.S. population. Environ. Res. 111(1):110-118. Nermell, B., A.L. Lindberg, M. Rahman, M. Berglund, L. Persson, S. El Airfeen, and M. Vahter. 2008. Urinary ar- senic concentration adjustment factors and malnutrition. Environ. Res. 106(2):212-218. Nesnow, S., B.C. Roop, G. Lambert, M. Kadiiska, R.P. Mason, W.R. Cullen, and M.J. Mass. 2002. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15(12):1627-1634. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press. NRC (National Research Council). 1999. Arsenic in Drinking Water. Washington, DC: National Academy Press. NRC (National Research Council). 2001. Arsenic in Drinking Water: 2001 Update. Washington, DC: National Academy Press. NRC (National Research Council). 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washing- ton, DC: The National Academies Press. NRC (National Research Council). 2009. Science and Decisions: Advancing Risk Assessment. Washington, DC: The National Academies Press. NRC (National Research Council). 2011. Review of the Environmental Protection Agency’s Draft IRIS Assessment of Formaldehyde. Washington, DC: The National Academies Press. O'Bryant, S.E., M. Edwards, C.V. Menon, G. Gong, and R. Barber. 2011. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: A Project FRONTIER study. Int. J. Environ. Res. Public Health 8(3):861-874.

OCR for page 84
References 101 Olsen, C.E., A.E. Liguori, Y. Zong, R.C. Lantz, J.L. Burgess, and S. Boitano. 2008. Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 295(2):L293- L302. Orsini, N., R. Li, A. Wolk, P. Khudyakov, and D. Spiegelman. 2012. Meta-analysis for linear and nonlinear dose- response relations: Examples, an evolution of approximations, and software. Am. J. Epidemiol. 175(1):66-73. Padovani, A.M., M.F. Molina, and K.K. Mann. 2010. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Arterioscler. Thromb. Vasc. Biol. 30(6):1228-1236. Pan, W.C., M.L. Kile, W.J. Seow, X. Lin, Q. Quamruzzaman, M. Rahman, G. Mahiuddin, G. Mostofa, Q. Lu, and D.C. Christiani. 2013. Genetic susceptible locus in NOTCH2 interacts with arsenic in drinking water on risk of type 2 diabetes. PLoSOne. 8(8):e70792. Parvez, F., Y. Chen, P.W. Brandt-Rauf, A. Bernard, X. Dumont, V. Slavkovich, M. Argos, J. D'Armiento, R. Foronjy, M.R. Hasan, H.E. Eunus, J.H. Graziano, and H. Ahsan. 2008. Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ. Health Perspect. 116(2):190-195. Parvez, F., Y. Chen, P.W. Brandt-Rauf, V. Slavkovich, T. Islam, A. Ahmed, M. Argos, R. Hassan, M. Yunus, S.E. Haque, O. Balac, J.H. Graziano, and H. Ahsan. 2010. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax 65(6):528-533. Parvez, F., G.A. Wasserman, P. Factor-Litvak, X. Liu, V. Slavkovich, A.B. Siddique, R. Sultana, T. Islam, D. Levy, J.L. Mey, A. van Geen, K. Khan, J. Kline, H. Ahsan, and J.H. Graziano. 2011. Arsenic exposure and motor function among children in Bangladesh. 119(11):1665-1670. Parvez, F., Y. Chen, M. Yunus, C. Olopade, V. Slavkovich, J. Graziano, and H. Ahsan. 2013. Arsenic exposure and impaired lung function: Findings from a large population-based perspective cohort study. Am. J. Resp. Crit. Care Med. doi: 10.1164/rccm.201212-2282OC. Patel, H.V., and K. Kalia. 2010. Sub-chronic arsenic exposure aggravates nephrotoxicity in experimental diabetic rats. Indian J. Exp. Biol. 48(7):762-768. Paul, D.S., F.S. Walton, R.J. Saunders, and M. Styblo. 2011. Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ. Health Perspect. 119(8):1104-1109. Pei, Q., N. Ma, J. Zhang, W. Xu, Y. Li, Z. Ma, Y. Li, F. Tian, W. Zhang, J. Mu, Y. Li, D. Wang, H. Liu, M. Yang, C. Ma, and F. Yun. 2013. Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, se- lectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions. Tox- icol. Appl. Pharmacol. 266(1):143-149. Peraza, M.A., D.E. Carter, and A.J. Gandolfi. 2003. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol. Toxicol. 19(4):253-264. Petrick, J.S., F.M. Blachere, O. Selmin, and R.C. Lantz. 2009. Inorganic arsenic as a developmental toxicant: In utero exposure and alterations in the developing rat lungs. Mol. Nutr. Food Res. 53(5):583-591. Pierce, B.L., M. Argos, Y. Chen, S. Melkonian, F. Parvez, T. Islam, A. Ahmed, R. Hasan, P.J. Rathouz, and H. Ahsan. 2011. Arsenic exposure, dietary patterns, and skin lesion risk in Bangladesh: A prospective study. Am. J. Epidemiol. 173(3):345-354. Pierce, B.L., M.G. Kibriya, L. Tong, F. Jasmine, M. Argos, S. Roy, R. Paul-Brutus, R. Rahaman, M. Rakibuz- Za- man, F. Parvez, A. Ahmed, I. Quasem, S.K. Hore, S. Alam, T. Islam, V. Slavkovich, M.V. Gamble, M. Yunus, M. Rahman, J.A. Baron, J.H. Graziano, and H. Ahsan. 2012. Genome-wide association study iden- tifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bang- ladesh. PLoS Genet. 8(2): e1002522. Pili, R., and R. Rodriguez. 2008. Cancer of the kidney. Chapter 86 in Abeloff’s Clinical Oncology, Fourth Edition, M.D. Abeloff, J.O. Armitage, J.E. Niederhuber, M.B. Kastan, and W.G. McKenna, eds. Phildelphia, PA: Elsevier Churchill-Livingstone. Pilsner, J.R., X. Liu, H. Ahsan, V. Ilievski, V. Slavkovich, D. Levy, P. Factor-Litvak, J.H. Graziano, and M.V. Gamble. 2009. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 117(2):254-260. Pilsner, J.R., M.N. Hall, X. Liu, H. Ahsan, V. Ilievski, V. Slavkovich, D. Levy, P. Factor-Litvak, J.H. Graziano, and M.V. Gamble. 2011. Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in Bangladesh. Environ. Health Perspect. 119(1):113-118.

OCR for page 84
102 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Pilsner, J.R., M.N. Hall, X. Liu, V. Ilievski, V. Slavkovich, D. Levy, P. Factor-Litvak, M. Yunus, M. Rahman, J.H. Graziano, and M.V. Gamble. 2012. Influence of prenatal arsenic exposure and newborn sex on global methyl- ation of cord blood DNA. PLoS One. 7(5):e37147. Plenge, R.M., C. Cotsapas, L. Davies, A.L. Price, P.I. de Bakker, J. Maller, I. Pe'er, N.P. Burtt, B. Blumenstiel, M. De- Felice, M. Parkin, R. Barry, W. Winslow, C. Healy, R.R. Graham, B.M. Neale, E. Izmailova, R. Roubenoff, A.N. Parker, R. Glass, E.W. Karlson, N. Maher, D.A. Hafler, D.M. Lee, M.F. Seldin, E.F. Remmers, A.T. Lee, L. Padyukov, L. Alfredsson, J. Coblyn, M.E. Weinblatt, S.B. Gabriel, S. Purcell, L. Klareskog, P.K. Gregersen, N.A. Shadick, M.J. Daly, and D. Altshuler. 2007. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39(12):1477-1482. Pomroy, C., S.M. Charbonneau, R.S. McCullough, and G.K. Tam. 1980. Human retention studies with 74As. Toxi- col. Appl. Pharmacol. 53(3):550-556. Pope, C.A., 3rd, R.T. Burnett, G.D. Thurston, M.J. Thun, E.E. Calle, D. Krewski, and J.J. Godleski. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 109(1):71-77. Porta, M. 2008. A Dictionary of Epidemiology, Fifth Edition. New York; Oxford University Press. Pysher, M.D., J.J. Sollome, S. Regan, T.R. Cardinal, J.B. Hoying, H.L. Brooks, and R.R. Vaillancourt. 2007. In- creased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicol. Appl. Pharmacol. 224(1):39-48. Qin, S.P., J. Kim, D. Arafat, and G. Gibson. 2013. Effect of normalization on statistical and biological interpretation of gene expression profiles. Front. Genet. 3:160. Qui, X., H. Wu, and R. Hu. 2013. The impact of quantile and rank normalization procedures on the testing power of gene differential expression analysis. BMC Bioinformatics 14:124. Raab, A., and J. Feldmann. 2005. Arsenic speciation in hair extracts. Anal. Bioanal. Chem. 381(2):332-338. Rahman, A., M. Vahter, E.C. Ekström, M. Rahman, A. Haider, M.G. Mustafa, M.A. Wahed, M. Yunus, and L.Å. Persson. 2007. Association of arsenic exposure during pregnancy with fetal loss and infant death: A cohort study in Bangladesh. Am. J. Epidemiol. 165(12):1389-1396. Rahman, A., M. Vahter, A.H. Smith, B. Nermell, M. Yunus, S. El Arifeen, L.Å. Persson, and E.C. Ekström. 2009. Arsenic exposure during pregnancy and size at birth: A prospective cohort study in Bangladesh. Am. J. Ep- idemiol. 169(3):304-312. Rahman, A., L.Å. Persson, B. Nermell, S. El Arifeen, E.C. Ekström, A.H. Smith, and M. Vahter. 2010. Arsenic ex- posure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21(6):797-804. Rahman, A., M. Vahter, E.C. Ekström, and L.A. Persson. 2011. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ. Health Perspect. 119(5):719-724. Rahman, M., M. Vahter, N. Sohel, M. Yunus, M.A. Wahed, P.K. Streatfield, E.C. Ekström, and L.A. Persson. 2006. Arsenic exposure and age- and sex-specific risk for skin lesions: A population-based case-referent study in Bangladesh. Environ. Health Perspect. 114(12):1847-1852. Raml, R., A. Rumpler, W. Goessler, M. Vahter, L. Li, T. Ochi, and K.A. Francesconi. 2007. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. 222(3):374-380. Ramsey, K.A., A. Bosco, K.L. McKenna, K.W. Carter, J.G. Elliot, L.J. Berry, P.D. Sly, A.N. Larcombe, and G.R. Zosky. 2013a. In utero exposure to arsenic alters lung development and genes related to immune and mu- cociliary function in mice. Environ. Health Perspect. 121(2):244-250. Ramsey, K.A., A.N. Larcombe, P.D. Sly, and G.R. Zosky. 2013b. In utero exposure to low dose arsenic via drinking water impairs early life lung mechanics in mice. BMC Pharmacol Toxicol. 14(1):13. Ranft, U., P. Miskovic, B. Pesch, P. Jakubis, E. Fabianova, T. Keegan, A. Hergemoller, M. Jakubis, and M.J. Nieuwenhuijsen. 2003. Association between arsenic exposure from a coal-burning power plant and urinary arsenic concentrations in Prievidza District, Slovakia. Environ. Health Perspect. 111(7):889-894. Rao, M.V., and G. Avani. 2004. Arsenic induced free radical toxicity in brain of mice. Indian J. Exp. Biol. 42(5):495-498. Rebbeck, T.R., C.B. Ambrosone, D.A. Bell, S.J. Chanock, R.B. Hayes, F.F. Kadlubar, and D.C. Thomas. 2004. SNPs, haplotypes, and cancer: Applications in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 13(5):681-687. Reichard, J.F., and A. Puga. 2010. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2(1):87-104.

OCR for page 84
References 103 Rhomberg, L.R., J.E. Goodman, L.T. Haber, M. Dourson, M.E. Andersen, J.E. Klaunig, B. Meek, P.S. Price, R.O. McClellan, and S.M. Cohen. 2011. Linear low-dose extrapolation for noncancer heath effects is the excep- tion, not the rule. Crit. Rev. Toxicol. 41(1):1-19. Riley, R.D., P.C. Lambert, and G. Abo-Zaid. 2010. Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ 340:c221. Rivara, M.I., M. Cebrian, G. Corey, M. Hernandez, and I. Romieu. 1997. Cancer risk in an arsenic-contaminated area of Chile. Toxicol. Ind. Health 13(2-3):321-338. Rodriguez, V.M., L. Carrizales, M.S. Mendoza, O.R. Fajardo, and M. Giordano. 2002. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 24(6):743-750. Rodriguez-Barranco, M., M. Lacasana, C. Aguilar-Garduno, J. Alguacil, F. Gil, B. Gonzalez-Alzaga, and A. Rojas- Garcia. 2013. Association of arsenic, cadmium and manganese exposure with neurodevelopment and behavioural disorders in children: A systematic review and meta-analysis. Sci. Total Environ. 454-455:562- 577. Rodriguez-Murillo, L., and D.A. Greenberg. 2008. Genetic association analysis: a primer on how it works, its strengths and its weaknesses. Int. J. Androl. 31(6):546-556. Rooney, A. 2013. Systematic Review and Evidence Integration for Literature-Based Environmental Health Assess- ments. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Rosado, J.L., D. Ronquillo, K. Kordas, O. Rojas, J. Alatorre, P. Lopez, G. Garcia-Vargas, M.E. Del Carmen Caama- ño, M.E. Cebrián, and R.J. Stoltzfus. 2007. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ. Health Perspect. 115(9):1371-1375. Rosales-Castillo, J.A., L.C. Acosta-Saavedra, R. Torres, J. Ochoa-Fierro, V.H. Borja-Aburto, L. Lopez-Carrillo, G.G. Garcia-Vargas, G.B. Gurrola, M.E. Cebrian, and E.S. Calderon-Aranda. 2004. Arsenic exposure and human papillomavirus response in non-melanoma skin cancer Mexican patients: A pilot study. Int. Arch. Occup. Environ. Health. 77(6):418-423. Rota, M., R. Bellocco, L. Scotti, I. Tramacere, M. Jenab, G. Corrao, C. La Vecchia, P. Boffetta, and V. Bagnardi. 2010. Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma. Stat. Med. 29(26):2679-2687. Roy, A., K. Kordas, P. Lopez, J.L. Rosado, M.E. Cebrian, G.G. Vargas, D. Ronquillo, and R.J. Stoltzfus. 2011. As- sociation between arsenic exposure and behavior among first-graders from Torreón, Mexico. Environ. Res. 111(5):670-676. Saha, K.K., A. Engström, J.D. Hamadani, F. Tofail, K.M. Rasmussen, and M. Vahter. 2012. Pre-and postnatal arse- nic exposure and body size to 2 years of age: A cohort study in rural Bangladesh. Environ. Health Perspect. 120(8):1208-1214. Sande, K. 2013. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Sawada, N., M. Iwasaki, M. Inoue, R. Takachi, S. Sasazuki, T. Yamaji, T. Shimazu, and S. Tsugane. 2013. Dietary arsenic intake and subsequent risk of cancer: The Japan Public Health Center-based (JPHC) Prospective Study. Cancer Causes Control 24(7):1403-1415. Schadt, E.E., and J.L. Björkegren. 2012. NEW: Network-enabled wisdom in biology, medicine, and health care. Sci. Transl. Med. 4(115):115rv1. doi: 10.1126/scitranslmed.3002132. Schlebusch, C.M., C.M. Lewis, Jr., M. Vahter, K. Engström, R.Y. Tito, A.J. Obregon-Tito, D. Huerta, S.I. Polo, A.C. Medina, T.D. Brutsaert, G. Concha, M. Jakobsson, and K. Broberg. 2013. Possible positive selection for an arsenic-protective haplotype in humans. Environ. Health Perspect. 121(1):53-58. Schoof, R.A., L.J. Yost, J. Eickhoff, E.A. Crecelius, D.W. Cragin, D.M. Meacher, and D.B. Menzel. 1999. A market basket survey of inorganic arsenic in food. Food Chem. Toxicol. 37(8):839-846. Schwartz, J. 1994. Societal benefits of reducing lead exposure. Environ. Res. 66(1):105-124. Schwartz, J. 2013. Risk Assessment and Epidemiology. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC. Schwartz, J., F. Laden, and A. Zanobetti. 2002. The concentration-response relation between PM2.5 and daily deaths. Environ. Health Perspect. 110(10):1025-1029. Shen, S., J. Lee, M. Weinfeld, and X.C. Le. 2008. Attenuation of DNA damage-induced p53 expression by arsenic: A possible mechanism for arsenic co-carcinogenesis. Mol. Carcinog. 47(7):508-518. Simeonova, P.P., and M.I. Luster. 2002. Arsenic carcinogenicity: Relevance of c-Src activation. Mol. Cell Biochem. 234-235(1-2):277-282.

OCR for page 84
104 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Simpkins, J.W., J.A. Swenberg, N. Weiss, D. Brusick, J.C. Eldridge, J.T. Stevens, R.J. Handa, R.C. Hovey, T.M. Plant, T.P. Pastoor, and C.B. Breckenridge. 2011. Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence. Toxicol. Sci. 123(2):441-459. Sińczuk-Walczak, H., M. Szymczak, and T. Halatek. 2010. Effects of occupational exposure to arsenic on the nerv- ous system: Clinical and neurophysiological studies. Int. J. Occup. Med. Environ. Health 23(4):347-355. Singh, K.P., R. Kumari, J. Treas, and J.W. Dumond. 2011. Chronic exposure to arsenic causes increased cell surviv- al, DNA damage, and increased expression of mitochondrial transcription factor A (mtTFA) in human prostate epithelial cells. Chem. Res. Toxicol. 24(3):340-349. Slikker, W., Jr., M.E. Anderson, M.S. Bogdanffy, J.S. Bus, S.D. Cohen, R.B. Conolly, R.M. David, N.G. Doerrer, D.C. Dorman, D.W. Gaylor, D. Hattis, J.M. Rogers, R.W. Setzer, J.A. Swenberg, and K. Wallace. 2004a. Dose-dependent transactions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 201(3):203-225. Slikker, W., Jr., M.E. Anderson, M.S. Bogdanffy, J.S. Bus, S.D. Cohen, R.B. Conolly, R.M. David, N.G. Doerrer, D.C. Dorman, D.W. Gaylor, D. Hattis, J.M. Rogers, R.W. Setzer, J.A. Swenberg, and K. Wallace. 2004b. Dose- dependent transitions in mechanisms of toxicity: Case studies. Toxicol. Appl. Pharmacol. 201(3):226-294. Slotnick, M.J., and J.O. Nriagu. 2006. Validity of human nails as a biomarker of arsenic and selenium exposure: A review. Environ. Res. 102(1):125-139. Smeester, L., J.E. Rager, K.A. Bailey, X. Guan, N. Smith, G. Garcia-Vargas, L.M. Del Razo, Z. Drobna, H. Kelkar, M. Styblo, and R.C. Fry. 2011. Epigenetic changes in individuals with arsenicosis. Chem. Res. Toxicol. 24(2):165-167. Smith, A.H., M. Goycolea, R. Haque, and M.L. Biggs. 1998. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147(7):660-669. Smith, A.H., G. Marshall, Y. Yuan, C. Ferreccio, J. Liaw, O. von Ehrenstein, C. Steinmaus, M.N. Bates, and S. Sel- vin. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114(8):1293-1296. Smith, A.H., A. Ercumen, Y. Yuan, and C.M. Steinmaus. 2009. Increased lung cancer risks are similar whether ar- senic is ingested or inhaled. J. Expo. Sci. Environ. Epidemiol. 19(4):343-348. Smith, A.H., G. Marshall, Y. Yuan, J. Liaw, C. Ferreccio, and C. Steinmaus. 2011. Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am. J. Epidemiol. 173(4):414-420. Smith, A.H., G. Marshall, J. Liaw, Y. Yuan, C. Ferreccio, and C. Steinmaus. 2012. Mortality in young adults fol- lowing in utero and childhood exposure to arsenic in drinking water. Environ. Health Perspect. 120(11): 1527-1531. Smyth, G.K. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:3. Snow, E.T., P. Sykora, T.R. Durham, and C.B. Klein. 2005. Arsenic, mode of action at biologically plausible low dos- es: What are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol. 207(2 suppl.):557-564. Sohel, N., L.A. Persson, M. Rahman, P.K. Streatfield, M. Yunus, E.C. Ekström, and M. Vahter. 2009. Arsenic in drinking water and adult mortality: A population-based cohort study in rural Bangladesh. Epidemiology 20(6):824-830. Sonenson, C., and M. Delorenzi. 2013. A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinforma. 14:91. Sonich-Mullin, C., R. Fielder, J. Wiltse, K. Baetcke, J. Dempsey, P. Fenner-Crisp, D. Grant, M. Hartley, A. Knaap, D. Kroese, I. Mangelsdorf, E. Meek, J.M. Rice, and M. Younes. 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34(2):146-152. Soucy, N.V., D. Mayka, L.R. Klei, A.A. Nemec, J.A. Bauer, and A. Barchowsky. 2005. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc. Toxicol. 5(1):29-41. Spinola, M., V.P. Leoni, A. Galvan, E. Korsching, B. Conti, U. Pastorino, F. Ravagnani, A. Columbano, V. Skaug, A. Haugen, and T.A. Dragani. 2007. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett. 251(2):311-316. Srivastava, S., S.E. D’Souza, U. Sen, and J.C. States. 2007. In utero arsenic exposure induces early onset of athero- sclerosis in ApoE -/- mice. Reprod. Toxicol. 23:449-456. States, J.C., S. Srivastava, Y. Chen, and A. Barchowsky. 2009. Arsenic and cardiovascular disease. Toxicol. Sci. 107(2):312-323. States, J.C., A. Barchowsky, I.L. Cartwright, J.F. Reichard, B.W. Futscher, and R.C. Lantz. 2011. Arsenic toxicology: Translating between experimental models and human pathology. Environ. Health Perspect. 119(10):1356-1363.

OCR for page 84
References 105 Steinmaus, C. 2013. Non-cancer Outcomes and Ingested Arsenic. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washing- ton, DC. Steinmaus, C., Y. Yuan, M.N. Bates, and A.H. Smith. 2003. Case-control study of bladder cancer and drinking wa- ter arsenic in the western United States. Am. J. Epidemiol. 158(12):1193-1201. Steinmaus, C., Y. Yuan, D. Kalman, R. Atallah, and A.H. Smith. 2005. Intraindividual variability in arsenic methyl- ation in a US population. Cancer Epidemiol. Biomarkers Prev. 14(4):919-924. Steinmaus, C., Y. Yuan, J. Liaw, and A.H. Smith. 2009. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: A reanalysis. Epidemiology 20(6):807-815. Steinmaus, C., Y. Yuan, D. Kalman, O.A. Rey, C.F. Skibola, D. Dauphine, A. Basu, K.E. Porter, A. Hubbard, M.N. Bates, M.T. Smith, and A.H. Smith. 2010. Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol. Appl. Pharmacol. 247(2):138-145. Steinmaus, C.M., C. Ferreccio, J.A. Romo, Y. Yuan, S. Cortes, G. Marshall, L.E. Moore, J.R. Balmes, J. Liaw, T. Golden, and A.H. Smith. 2013. Drinking water arsenic in northern Chile: High cancer risks 40 years after exposure cessation. Cancer Epidemiol. Biomarkers Prev. 22(4):623-630. Stoica, A., E. Pentecost, and M.B. Martin. 2000. Effects of arsenite on estrogen receptor-alpha expression and ac- tivity in MCF-7 breast cancer cells. Endocrinology 141(10):3595-3602. Straub, A.C., K.A. Clark, M.A. Ross, A.G. Chandra, S. Li, X. Gao, P.J. Pagano, D.B. Stolz, and A. Barchowsky. 2008. Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J. Clin. Invest. 118(12):3980-3989. Stueckle, T, A., Y. Lu, M.E. Davis, L. Wang, B.H. Jiang, I. Holaskova, R. Schafer, J.B. Barnett, and Y. Rojanasa- kul. 2012. Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and ne- oplastic transformation in human lung epithelial cells. Toxicol. Appl. Pharmacol. 261(2):204-216. Styblo, M., H. Yamauchi, and D.J. Thomas. 1995. Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol. Appl. Pharmacol. 135(2):172-178. Styblo, M., L.M. Del Razo, L. Vega, D.R. Germolec, E.L. LeCluyse, G.A. Hamilton, W. Reed, C. Wang, W.R. Cul- len, and D.J. Thomas. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated ar- senicals in rat and human cells. Arch. Toxicol. 74(6):289-299. Styblo, M., Z. Drobna, I. Jaspers, S. Lin, and D.J. Thomas. 2002. The role of biomethylation in toxicity and carcino- genicity of arsenic: a research update. Environ. Health Perspect. 110 (Suppl. 5):767-771. Subramanian, A., P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102(43):15545-15550. Sung, T.I., Y.J. Wang, C.Y. Chen, T.L. Hung, and H.R. Guo. 2012. Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic. Sci. Total. Environ. 424:74-78. Suzuki, S., L.L. Arnold, T. Ohnishi, and S.M. Cohen. 2008a. Effects of inorganic arsenic on the rat and mouse urinary bladder. Toxicol. Sci. 106(2):350-363. Suzuki, S., L.L. Arnold, D. Muirhead, X. Lu, X.C. Le, J.A. Bjork, K.B. Wallace, T. Ohnishi, S. Kakiuchi-Kiyota, K.L. Pennington, and S.M. Cohen. 2008b. Inorganic arsenic-induced intramitochondrial granules in mouse urothe- lium. Toxicol. Pathol. 36(7):999-1005. Suzuki, S., L.L. Arnold, K.L. Pennington, B. Chen, X.C. Le, and S.M. Cohen. 2009a. Effects of an epidermal growth factor receptor inhibitor on arsenic associated toxicity in the rat bladder epithelium. Toxicol. Lett. 187(2):124- 129. Suzuki, S., L.L. Arnold, K.L. Pennington, S. Kakiuchi-Kiyota, and S.M. Cohen. 2009b. Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium. Toxicology 261(1- 2):41-46. Suzuki, S., L.L. Arnold, K.L. Pennington, B. Chen, H. Naranmandura, X.C. Le, and S.M. Cohen. 2010. Dietary admin- istration of sodium arsenite to rats: Relations between dose and urinary concentrations of methylated and thio- metabolites and effects on the rat urinary bladder epithelium. Toxicol. Appl. Pharmacol. 244(2):99-105. Suzuki, S., L.L. Arnold, K.L. Pennington, S. Kakiuchi-Kiyota, B. Chen, X. Lu, X.C. Le, and S.M. Cohen. 2012. Effects of co-administration of dietary sodium arsenate and 2,3-dimercaptopropane-1-sulfonic acid (DMPS) on the rat bladder epithelium. Toxicology 299(2-3):155-159.

OCR for page 84
106 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Tam, G.K., S.M. Charbonneau, F. Bryce, C. Pomroy, and E. Sandi. 1979. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50(2):319-322. Tao, S., Y. Zheng, A. Lau, M.C. Jaramillo, B.T. Chau, R.C. Lantz, P.K. Wong, G.T. Wondrak, and D.D. Zhang. 2013. Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid. Redox Signal. doi: 10.1089/ars.2012.5117. Tellez-Plaza, M., M.O. Gribble, V.S. Voruganti, K.A. Francesconi, W. Goessler, J.G. Umans, E.K. Silbergeld, E. Guallar, N. Franceschini, K.E. North, W.H., Kao, J.W. MacCluer, S.A. Cole, and A. Navas-Acien. 2013. Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine. Environ. Health Perspect. 121(3):345-351. Thomas, D.J. 2013. Arsenic Metabolism, Its Consequences, and Implications for Low Dose Assessments. Presenta- tion at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose- Response Analysis, April 4, 2013, Washington, DC. Thomson, W., A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D. Symmons, S. Hider, I.N. Bruce, Well- come Trust Case Control Consortium, A.G. Wilson, I. Marinou, A. Morgan, P. Emery, YEAR Consortium, A. Carter , S. Steer, L. Hocking, D.M. Reid, P. Wordsworth, P. Harrison, D. Strachan, and J. Worthington. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39(12):1431-1433. Timchalk, C., T.S. Poet, M.N. Hinman, A.L. Busby, and A.A. Kousba. 2005. Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat. Toxicol. Appl. Pharmacol. 205(1):31-42. Tofail, F., M. Vahter, J.D. Hamadani, B. Nermell, S.N. Huda, M. Yunus, M. Rahman, and S.M. Grantham- McGregor. 2009. Effect of arsenic exposure during pregnancy on infant development at 7 months in rural Matlab, Bangladesh. Environ. Health Perspect. 117(2):288-293. Tokar, E.J., B.A. Diwan, and M.P. Waalkes. 2010a. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ. Health Perspect. 118(1):108-115. Tokar, E.J., B.A. Diwan, and M.P. Waalkes. 2010b. Arsenic exposure in utero and nonepidermal proliferative re- sponse in adulthood in Tg.AC mice. Int. J. Toxicol. 29(3):291-296. Tokar, E.J., L. Benbrahim-Tallaa, J.M. Ward, R. Lunn, R.L. Sams, II, and M.P. Waalkes. 2010c. Cancer in experi- mental animals exposed to arsenic and arsenic compounds. Crit. Rev. Toxicol. 40(10):912-927. Tokar, E.J., W. Qu, and M.P. Waalkes. 2011a. Arsenic, stem cells, and the developmental basis of adult cancer. Toxicol. Sci. 120(suppl. 1):192-203. Tokar, E.J., B.A. Diwan, J.M. Ward, D.A. Delker, and M.P. Waalkes. 2011b. Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol. Sci. 119(1):73-83. Tokar, E.J., B.A. Diwan, and M.P. Waalkes. 2012a. Renal, hepatic, pulmonary and adrenal tumors induced by pre- natal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice. Toxicol. Lett. 209(2):179-185. Tokar, E.J., R.J. Person, Y. Sun, A.O. Perantoni, and M.P. Waalkes. 2012b. Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype. Chem. Res. Toxicol. 26(1):96-105. Treas, J.N., T. Tyagi, and K.P. Singh. 2012. Effects of chronic exposure to arsenic and estrogen on epigenetic regu- latory gene expression and epigenetic code in human prostate epithelial cells. PloS One 7(8):e43880. Tsai, S.M., T.N. Wang, and Y.C. Ko. 1998. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement. J. Toxicol. Environ. Health A 55(6):389-404. Tsai, S.M., T.N. Wang, and Y.C. Ko. 1999. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 54(3):186-193. Tsai, S.Y., H.Y. Chou, H.W. The, C.M. Chen, and C.J. Chen. 2003. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24(4-5):747-753. Tseng, C.H., Y.K. Huang, Y.L. Huang, C.J. Chung, M.H. Yang, C.J. Chen, and Y.M. Hsueh. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 206(3):299-308. Tsuda, H., S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Waka- bayashi, and M.A. Moore. 2003. Value of GST-P positive preneoplastic hepatic foci in dose-response stud- ies of hepatocarcinogenesis: Evidence for practical thresholds with both genotoxic and nongenotoxic car- cinogens. A review of recent work. Toxicol. Pathol. 31(1):80-86. Tsuji, J.S. 2013. Brief Comments Regarding a Unified Dose-Response Assessment for Arsenic Cancer and Non- cancer Toxicity. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC.

OCR for page 84
References 107 Tusher, V.G., R. Tibshirani, and g. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98(():5116-5121. USGS (U.S Geological Survey). 2012. National Geochemical Survey: Selenium in Counties of the Conterminous States [online]. Available: http://mrdata.usgs.gov/geochem/doc/averages/se/usa.html [accessed June 17, 2013]. Vahter, M. 1999 Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82(Pt.1):69-88. Vahter, M. 2002. Mechanisms of arsenic biotransformation. Toxicology (181-182):211-217. Vahter, M. 2009. Effects of arsenic on maternal and fetal health. Annu. Rev. Nutr. 29:381-399. Vahter, M., and E. Marafante. 1987. Effect of low dietary intake of methionine, choline or proteins on the biotrans- formation of arsenite in the rabbit. Toxicol. Lett. 37(1):41-46. Vahter, M, R. Couch, B. Nermell, and R. Nilsson. 1995a. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133(2):262-268. Vahter, M., G. Concha, B. Nermell, R. Nilsson, F. Dulout, and A.T. Natarajan. 1995b. A unique metabolism of in- organic arsenic in native Andean women. Eur. J. Pharmacol. 293(4):455-462. Vahter, M.E., L. Li, B. Nermell, A. Rahman, S. El Arifeen, M. Rahman, L.A. Persson, and E.C. Ekström. 2006. Arsenic exposure in pregnancy: A population-based study in Matlab, Bangladesh. J. Health Popul. Nutr. 24(2):236-245. Valenzuela, O.L., V.H. Borja-Aburto, G.G. Garcia-Vargas, M.B. Cruz-Gonzalez, E.A. Garcia-Montalvo, E.S. Cal- deron-Aranda, and L.M. Del Razo. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113(3):250-254. Valko, M., H. Morris, and M.T. Cronin. 2005. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12(10):1161- 1208. van Es, M.A., P.W. Van Vught, H.M. Blauw, L. Franke, C.G. Saris, P.M. Andersen, L. Van Den Bosch, S.W. de Jong, R. van 't Slot, A. Birve, R. Lemmens, V. de Jong, F. Baas, H.J. Schelhaas, K. Sleegers, C. Van Broeckhoven, J.H. Wokke, C. Wijmenga, W. Robberecht, J.H. Veldink, R.A. Ophoff, and L.H. van den Berg. 2007. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: A genome-wide asso- ciation study. Lancet Neurol. 6(10):869-877. Vasan, R.S., M.G. Larson, J. Aragam, T.J. Wang, G.F. Mitchell, S. Kathiresan, C. Newton-Cheh, J.A. Vita, M.J. Keyes, C.J. O'Donnell, D. Levy, and E.J. Benjamin. 2007. Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study. BMC Med. Genet. 8(suppl.1):S2. Viswanathan, M., M.T. Ansari, N.D. Berkman, S. Chang, L. Hartling, M. McPheeters, P.L. Santaguida, T. Shamliyan, K. Singh, A. Tsertsvadze, and J.R. Treadwell. 2012. Chapter 5. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. Pp. 69-97 in Methods Guide for Effectiveness and Com- parative Effectiveness Reviews, AHRQ Publication No. 10(12)-EHC063-EF, April 2012. Rockville, MD: Agency for Healthcare Research and Quality. Available: http://www.effectivehealthcare.ahrq.gov/ [accessed July 13, 2013]. Vlaanderen, J., L. Portengen, N. Rothman, Q. Lan, H. Kromhout, and R. Vermeulen. 2010. Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ. Health Perspect. 118(4):526-532. von Ehrenstein, O.S., D.N. Mazumder, Y. Yuan, S. Samanta, J. Balmes, A. Sil, N. Ghosh, M. Hira-Smith, R. Haque, R. Purushothamam, S. Lahiri, S. Das, and A.H. Smith. 2005. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 162(6):533-541. von Ehrenstein, O.S., D.N. Guha Mazumder, M. Hira-Smith, N. Ghosh, Y. Yuan, G. Windham, A. Ghosh, R. Haque, S. Lahiri, D. Kalman, S. Das, and A.H. Smith. 2006. Pregnancy outcomes, infant mortality, and ar- senic in drinking water in West Bengal, India. Am. J. Epidemiol. 163(7):662-669. von Ehrenstein, O.S., S. Poddar, Y. Yuan, D.G. Mazumder, B. Eskenazi, A. Basu, M. Hira-Smith, N. Ghosh, S. La- hiri, R. Haque, A. Ghosh, D. Kalman, S. Das, and A.H. Smith. 2007. Children's intellectual function in re- lation to arsenic exposure. Epidemiology 18(1):44-51. Vorderstrasse, B.A., J.A. Cundiff, and B.P. Lawrence. 2006. A dose-response study of the effects of prenatal and lactational exposure to TCDD on the immune response to influenza a virus. J. Toxicol. Environ. Health A 69(6):445-463. Waalkes, M.P. 2013. Impact of In Utero and Whole Life Exposure in Rodents and Implications for Dose Response. Presentation at the Workshop- Inorganic Arsenic: Scientific Consideration for Hazard Identification and Dose-Response Analysis, April 4, 2013, Washington, DC.

OCR for page 84
108 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic Waalkes, M.P., J.M. Ward, J. Liu, and B.A. Diwan. 2003. Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186(1):7-17. Waalkes, M.P., J.M. Ward, and B.A. Diwan. 2004a. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: Promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25(1):133-141. Waalkes, M.P., J. Liu, H. Chen, Y. Xie, W.E. Achanzar, Y.S. Zhou, M.L. Cheng, and B.A. Diwan. 2004b. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96(6):466-474. Waalkes, M.P., J. Liu, J.M. Ward, and B.A. Diwan. 2006. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215(3):295-305. Wade, T.J., Y. Xia, K. Wu, Y. Li, Z. Ning, X.C. Le, X. Lu, Y. Fong, X. He, and J.L. Mumford. 2009. Increased mortality associated with well-water arsenic exposure in Inner Mongolia, China. Int. J. Environ. Res. Pub- lic Health 6(3):1107-1123. Wang, A., S.D. Holladay, D.C. Wolf, S.A. Ahmed, and J.L. Robertson. 2006. Reproductive and developmental tox- icity of arsenic in rodents: A review. Int. J. Toxicol. 25(5):319-331. Wang, C.H., C.K. Hsiao, C.L. Chen, L.I. Hsu, H.Y. Chiou, S.Y. Chen, Y.M. Hsueh, M.M. Wu, and C.J. Chen. 2007. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol. Appl. Pharmacol. 222(3):315-326. Wang, G., and B.A. Fowler. 2008. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol. Appl. Pharmacol. 233(1):92-99. Wang, J.P., S.L. Wang, Q. Lin, L. Zhang, D. Huang, and J.C. Ng. 2009. Association of arsenic and kidney dysfunc- tion in people with diabetes and validation of its effects in rats. Environ. Int. 35(3):507-511. Wang, L., Y.O. Son, S. Ding, X. Wang, J.A. Hitron, A. Budhraja, J.C. Lee, Q. Lin, P. Poyil, Z. Zhang, J. Luo, and X. Shi. 2012. Ethanol enhances tumor angiogenesis in vitro induced by low-dose arsenic in colon cancer cells through hypoxia-inducible factor 1 alpha pathway. Toxicol. Sci. 130(2):269-280. Wang, S.L., J.M. Chiou, C.J. Chen, C.H. Tseng, W.L. Chou, C.C. Wang, T.N. Wu, and L.W. Chang. 2003. Preva- lence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis- endemic and nonendemic areas in Taiwan. Environ. Health Perspect. 111(2):155-159. Wang, S.L., F.H. Chang, S.H. Liou, H.J. Wang, W.F. Li, and D.P. Hsieh. 2007. Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ. Int. 33(6):805-811. Wang, S.X., Z.H. Wang, X.T. Cheng, J. Li, Z.P. Sang, X.D. Zhang, L.L. Han, X.Y. Qiao, Z.M. Wu, and Z.Q. Wang. 2007. Arsenic and fluoride exposure in drinking water: Children’s IQ and growth in Shanyin county, Shan- xi province, China. Environ. Health Persepct. 115(4):643-647. Wang, X.J., Z. Sun, W. Chen, K.E. Eblin, J.A. Gandolfi, and D.D. Zhang. 2007. Nrf2 Protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol. Appl. Pharmacol. 225(2):206-213. Wang, Y., S. Li, F. Piao, Y. Hong, P. Liu, and Y. Zhao. 2009. Arsenic down-regulates the expression of Camk4, an important gene related to cerebellar LTD in mice. Neurotoxicol. Teratol. 31(5):318-322. Wang, Z., J. Yang, T. Fisher, H. Xiao, Y. Jiang, and C. Yang. 2012. Akt activation is responsible for enhanced mi- gratory and invasive behavior of arsenictransformed human bronchial epithelial cells. Environ. Health Per- spect. 120(1):92-97. Wasserman, G.A., X. Liu, F. Parvez, H. Ahsan, P. Factor-Litvak, A. van Geen, V. Slavkovich, N.J. LoIacono, Z. Cheng, I. Hussain, H. Momotaj, and J.H. Graziano. 2004. Water arsenic exposure and children’s intellectu- al function in Araihazar, Bangladesh. Environ. Health Perspect. 112(13):1329-1333. Wasserman, G.A., X. Liu, F. Parvez, H. Ahsan, P. Factor-Litvak, J. Kline, A. van Geen, V. Slavkovich, N.J. Loi- acono, D. Levy, Z. Cheng, and J.H. Graziano. 2007. Water arsenic exposure and intellectual function in 6- year-old children in Araihazar, Bangladesh. Environ. Health Perspect. 115(2):285-289. Wasserman, G.A., X. Liu, F. Parvez, P. Factor-Litvak, H. Ahsan, D. Levy, J. Kline, A. van Geen, J. Mey, V. Slav- kovich, A.B. Siddique, T. Islam, and J.H. Graziano. 2011. Arsenic and manganese exposure and children's intellectual function. Neurotoxicology 32(4):450-457. Watanabe, C., T. Inaoka, T. Kadono, M. Nagano, S. Nakamura, K. Ushijima, N. Murayama, K. Miyazaki, and R. Ohtsuka. 2001. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: Analyses based on urinary arsenic. Environ. Health Perspect. 109(12):1265-1270.

OCR for page 84
References 109 Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661-678. Wheeler, M.B., and A.J. Bailer. 2009. Comparing model averaging with other model selection strategies for bench- mark dose estimation. Environ. Ecol. Stat. 16:37-51. White, R.H., I. Cote, L. Zeise, M. Fox, F. Dominici, T.A. Burke, P.D. White, D.B. Hattis, and J.M. Samet. 2009. State-of-the-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment. Environ. Health Perspect. 117(2):283-287. Wiencke, J.K., J.W. Yager, A. Varkonyi, M. Hultner, and L.H. Lutze. 1997. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386(3):335- 344. Williams, P.N., A. Raab, J. Feldmann, and A.A. Maharg. 2007. Market basket survey shows elevated levels of As in South Central U.S. processed rice compared to California: Consequences for human dietary exposure. En- viron. Sci. Technol. 41(7):2178-2183. Wood, D.L., S.G. Sheps, L.R. Elveback, and A. Schirger. 1984. Cold pressor test as a predictor of hypertension. Hypertension 6(3):301-306. Wright, R.O., C. Amarasiriwardena, A.D. Woolf, R. Jim, and D.C. Bellinger. 2006. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 27(2):210-216. Wright, R.O., and D. Christiani. 2010. Gene-environment interaction and children’s health and development. Curr. Opin. Pediatr. 22(2):197-201. Wu, F., F. Jasmine, M.G. Kibriya, M. Liu, O. Wojcik, F. Parvez, R. Rahaman, S. Roy, R. Paul-Brutus, S. Segers, V. Slavkovich, T. Islam, D. Levy, J.L. Mey, A. van Geen, J.H. Graziano, H. Ahsan, and Y. Chen. 2012. Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers. Am. J. Epidemiol. 175(12):1252-1261. Wu, M.M., T.L. Kuo, Y.H. Hwang, and C.J. Chen. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130(6):1123-1132. Xi, S., W. Sun, F. Wang, Y. Jin, and G. Sun. 2009. Transplacental and early life exposure to inorganic arsenic af- fected development and behavior in offspring rats. Arch. Toxicol. 83(6):549-556. Xi, S., Y. Jin, X. Lv, and G. Sun. 2010. Distribution and speciation of arsenic by transplacental and early life expo- sure to inorganic arsenic in offspring rats. Biol. Trace Elem. Res. 134(1):84-97. Xie, Y., J. Liu, L. Benbrahim-Tallaa, J.M. Ward, D. Logsdon, B.A. Diwan, and M.P. Waalkes. 2007. Aberrant DNA methylation and gene expression in liver of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 236(1-2):7-15. Xue, D., W. Zhang, T. Liang, S. Zhao, B. Sun, and D. Sun. 2009. Effects of arsenic trioxide on the cerulein-induced AR42J cells and its gene regulation. Pancreas 38(7):E183-189. Xue, J., V. Zaratarian, S.W. Wang, and P. Georgopoulos. 2010. Probabilistic modeling of dietary arsenic exposure and dose and evaluation with 2003-2004 NHANES data. Environ. Health Perspect. 118(3):345-350. Yager, J.W., P.R. Gentry, R.S. Thomas, L. Pluta, A. Efremenko, M. Black, L.L. Arnold, J.M. McKim, P. Wilga, G. Gill, K.Y. Choe, and H.J. Clewell. 2013. Evaluation of gene expression changes in human primary uroepi- thelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites. Environ. Mol. Mutagen. 54(2):82-89. Yang, C.Y., C.C. Chang, S.S. Tsai, H.Y. Chuang, C.K. Ho, and T.N. Wu. 2003. Arsenic in drinking water and ad- verse pregnancy outcomes in an arseniasis-endemic area in northeastern Taiwan. Environ. Res. 91(1):29- 34. Yang, C.Y., H.F. Chiu, T.N. Wu, H.Y. Chuang, and S.C. Ho. 2004. Reduction in kidney cancer mortality following installation of a tap water supply system in an arsenic-endemic area of Taiwan. Arch. Environ. Health 59(9):484-488. Yang, C.Y., C.C. Chang, and H.F. Chiu. 2008. Does arsenic exposure increase the risk for prostate cancer? J. Toxi- col. Environ. Health A 71(23):1559-1563. Yang, R.S., and J.E. Dennison. 2007. Initial analyses of the relationship between "Thresholds" of toxicity for individual chemicals and "Interaction thresholds" for chemical mixtures. Toxicol. Appl. Pharmacol. 223(2):133-138. Yao, H., L. Guo, B.H. Jiang, J. Luo, and X. Shi. 2008. Oxidative stress and chromium(VI) carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 27(2):77-88. Yokohira, M., L.L. Arnold, K.L. Pennington, S. Suzuki, S. Kakiuchi-Kiyota, K. Herbin-Davis, D.J. Thomas, and S.M. Cohen. 2010. Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia

OCR for page 84
110 Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic induced by arsenite in arsenic (+3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol. Appl. Pharmacol. 246(1-2):1-7. Yorifuji, T., T. Tsuda, and P. Grandjean. 2010. Unusual cancer excess after neonatal arsenic exposure from contam- inated milk powder. J. Natl. Cancer Inst. 102(5):360-361. Yorifuji, T., T. Tsuda, H. Doi, and P. Grandjean. 2011. Cancer excess after arsenic exposure from contaminated milk powder. Environ. Health Prev. Med. 16(3):164-170. Yu, H.S., W.T. Liao, and C.Y. Chai. 2006. Arsenic carcinogenesis in the skin. J. Biomed. Sci. 13(5):657-666. Yu, R.C., K.H. Hsu, C.J. Chen, and J.R. Froines. 2000. Arsenic methylation capacity and skin cancer. Cancer Epi- demiol. Biomarkers Prev. 9(11):1259-1262. Yuan, Y., G. Marshall, C. Ferreccio, C. Steinmaus, S. Selvin, J. Liaw, M.N. Bates, and A.H. Smith. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 166(12):1381-1391. Yuan, Y., G. Marshall, C. Ferreccio, C. Steinmaus, J. Liaw, M. Bates, and A.H. Smith. 2010. Kidney cancer mortali- ty: Fifty-year latency patterns related to arsenic exposure. Epidemiology 21(1):103-108. Zanke, B.W., C.M. Greenwood, J. Rangrej, R. Kustra, A. Tenesa, S.M. Farrington, J. Prendergast, S. Olschwang, T. Chiang, E. Crowdy, V. Ferretti, P. Laflamme, S. Sundararajan, S. Roumy, J.F. Olivier, F. Robidoux, R. Sladek, A. Montpetit, P. Campbell, S. Bezieau, A.M. O'Shea, G. Zogopoulos, M. Cotterchio, P. Newcomb, J. McLaughlin, B. Younghusband, R. Green, J. Green, M.E. Porteous, H. Campbell, H. Blanche, M. Sahbatou, E. Tubacher, C. Bonaiti- Pellié, B. Buecher, E. Riboli, S. Kury, S.J. Chanock, J. Potter, G. Thomas, S. Gallinger, T.J. Hudson, and M.G. Dunlop. 2007. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39(8):989-994. Zeisel, S.H. 2011. Nutritional genomics: Defining dietary requirement and effects of choline. J. Nutr. 141(3):531- 534. Zhang, Y., D. Bhatia, H. Xia, V. Castranova, X. Shi, and F. Chen. 2006. Nucleolin links to arsenic-induced stabili- zation of GADD45alpha mRNA. Nucleic Acids Res. 34(2):485-495. Zhao, R., Y. Hou, Q. Zhang, C.G. Woods, P. Xue, J. Fu, K. Yarborough, D. Guan, M.E. Andersen, and J. Pi. 2012. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes. Environ. Health Perspect. 120(4):583-589. Zheng, H., E.O. Uthus, and G.F. Combs, Jr. 2005. Mechanistic aspects of the interaction between selenium and ar- senic. J. Inorg. Biochem. 99(6):1269-1274. Zheng, L.Y., J.G. Umans, M. Tellez-Plaza, F. Yeh, K.A. Francesconi, W. Goessler, E.K. Silbergeld, E. Guallar, B.V. Howard, V.M. Weaver, and A. Navas-Acien. 2013. Urine arsenic and prevalent albuminuria: Evi- dence from a population-based study. Am. J. Kidney Dis. 61(3):385-394. Zheng, Y., J. Wu, J.C. Ng, G. Wang, and W. Lian. 2002. The absorption and excretion of fluoride and arsenic in humans. Toxicol. Lett. 133(1):77-82. Zheng, Y, S. Tao, F. Lian, B.T. Chau, J. Chen, G. Sun, D. Fang, R.C. Lantz, and D.D. Zhang. 2012. Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response. Toxicol. Appl. Pharmacol. 265(3):292-299.